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The epiphysis cerebri or pineal gland has been a subject of inter-
est and speculation for over 2000 years. The ancient Greeks were the 
first to characterize the pineal gland describing it as a cone-shaped 
organ. In western civilization, Herophilos of Alexandria (325-280 
B.C.) was the first to develop a theory concerning the function of the 
pineal gland. He held that the gland functioned as a tap regulating 
the slrcam of "spiritus" from the third and fourth ventricles of the 
bt·a in. This view was held for over twenty centuries and was expanded 
on by the philosopher Descartis (1596-1650). He regarded the pineal 
gland as the scat of the soul, especially the seat of imagination, 
consc i.ousness and memory. However, shortly after publication Descartis' 
philosophies were refuted by several other philosophers including 
stensen and Kant. Interest in the mammalian pineal gland then waned 
until the early twentieth century. 
In the early twentieth century, several investigators concluded 
that the pineaL gland was probably a rudimentary organ which might have 
functional significance in early phylogenetic stages but had no im-
portance in mammals. The only importance attributed to this gland was 
its use as a point of orientation by the radiologists as a result of 
the electron dense concretions found in the pineal. 
1 
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Fortuitously, Heubner in 1898 described a boy suffering from a 
pinealoma who exhibited symptoms of premature puberty (Kappers, 1976). 
Several years later, this syndrome was named puberta praecox or genito-
somia praecox (Marburg, 1913, 1930). Clinical symptoms included a 
pineaLoma, premature development of the primary and secondary sexual 
organs and was found to occur mainly in boys. Its etiology was be-
lieved to be hypopinealism due to pineal degeneration or to destruction 
of' specific pineal parenchyma. The existence of hyperpinealism has 
also been described (Berkeley, 1926; Kappers, 1976). This syndrome is 
characterized by excessively slow and incomplete sexual development 
with a secondary general adiposity. Both hyperpinealism and hypopi-
nealism have been described in recent literature (Mincer et al., 1976; 
Kubo et al., 1977). 
As early as 1910, ablation experiments in rats (Thieblot, 1965) 
supported the clinical evidence relating the pineal gland with the 
reproductive syslem. These experiments demonstrated the appearance of 
ru·ccoc 1 ous secondary sexual characteristics, augmentation of testicular 
weight and development of the surface of the seminiferous tubules. 
~urther evidence, beginning in the 1930's and 1940's (Fischer, 1938; 
Fischer, 1943) and continuing into the 1970's (Wurtman et al., 1959; 
Milcu et al., 1963; Reiss, 1963; Soffer, 1965; Orts et al., l974a, 
l975b; Ebcls et al., 1970; Cheesman and Fariss, 1970b; Ota et al., 
1975) have demonstrated the antireproductive properties of pineal ex-
tracts. Hegardless of the chemical nature of the compound(s) eliciting 
l.he ef'f'ecl.s, all have demonstrated the abili.ty of these compounds to 
inhi.bit Lhc rcproducUve system either at the gonad, pituitary or 
hypothalamus. Two of these antireproductive compounds have been 
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isolated from the pineal and identified. Both the indoleamine mela-
l.onin (Lerner and Takahaski, 1960; Wurtman and Axelrod, 1965) and the 
pepl.ide ar·ginine vasotocin (AVT) (Milcu et al., 1963; Cheesman, l970a) 
have numerous antireproductive properties attributed to them, although 
both arc still controversial after two decades of research. 
This thesis will deal with the influence of the purported pineal 
hormone AVT on two of the reproductive hormones of the anterior 
pituitary. The effects of AVT on circulating levels of luteinizing 
hormone (LH) and prolactin in rats and on LH and prolactin release from 
hemisectioned pituitaries in in vitro incubation will be discussed. 
In summary, the reproductive effects of the pineal gland have been 
manifested clinically in such diseases as puberta praecox or hyper-
pincalism. Many ablation and replacement experiments have reinforced 
the ohserved clinical relationship between the pineal gland and the 
reproductive system and have further demonstrated the potent anti-
reproductive properties of pineal extracts. This thesis will examine 
Lhc relationship of the pineal peptide AVT and the adenohypophysial 
hormones LH and prolactin. 
CHAPTER II 
HEVIEW OF THE LITEHATUHE 
Modern research concerning the pineal gland was stimulated by 
Kitay and Altschule (1954) who reviewed the previous literature and 
concluded that although much of the literature was confusing and con-
tradictory, one could establish a statistical relationship between the 
pineal gland and gonadal function. 
Wurtman and others (Wurtman et al., 1959, 1961; Reiss et al., 
l963a, ]963b) in the late 1950's and early 1960's established are-
lationship between the pineal gland, pineal secretions, photoperiod 
and the reproductive system. This seemingly simple relationship has 
become an elusive enigma to interpret. 
Helationship Between Pineal and Photoperiod 
The relationship between the pineal gland and photoperiod has 
been a subject of intense research since Kitay and Altschules (1954) 
rekindled the interest in pineal physiology. Traditionally, the re-
lationship between photoperiod and melatonin synthesis has been used 
as an index of pineal-photoperiod relationship. 
It was determined that the indoleamine 5-hydroxytryptamine 
(serotonin) was first converted to N-acetylserotonin by the enzyme 
scrotonin-N-acctyltransferasc (NAT) (Weissbach, 1960). N-
acetylserotonin was then found to be converted to melatonin by the 
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enzyme hydroxyindole-0-methyltransferase (HIOMT) (Axelrod and Weiss-
bach, 1961 ). The relationship between photoperiod and melatonin 
synthesi.s was established when a decrease in pineal serotonin was ob-
served during darkness and elevated levels observed during periods of 
light exposure (Quay, 1963). Subsequently, an i.ncrease inN-
acelylscrotonin (Klein and Weller, 1973) and melatonin concentration 
both within the pineal gland (Lynch, 1971) and in the blood (Pehlam 
cL al., 1972) during the night has been observed. 
5 
Present dogma suggests that darkness is the stimulus for the re-
lease of norepinephrine from the pineal adrenergic endings (Deguchi and 
Axelrod, 1972). This catecholamine then acts via beta-adrenergic re-
ceptors to stimulate adenylate cyclase (Weiss and Costa, 1967) which 
results Ln an increase in cyclic AMP (Strada et al., 1972). This in-
crease in cyclic AMP then stimulates an increase in NAT (Deguchi and 
Axelrod, 1972). The enzyme HIOMT might also increase in activity 
during periods of darkness although there is disagreement concerning 
such a rhythm (Heiter, l976d). Whatever the case, the end result is 
an increase i.n melatonin synthesis and release during periods of dark-
ness. 
Anatomical studies corroborate the relationship between the eye 
and the pineal gland. Photic input into the pineal, as determined by 
HIOMT activity, originates from the inferior accessory optic tract 
(Moore et al., 1967; Moore et al., 1968). Leaving the main optic 
tract caudal to the optic chiasm, it terminates in the medial terminal 
nucleus of the inferior accessory optic tract (Hayhow et al., 1960). 
The tracts between the nucleus of the inferior accessory optic tract 
and the preganglionic fibers to the superior cervical ganglia have not 
6 
been traced. Extending from the superior cervical ganglia of the 
sympathetjc chain the tracts then innervate the pineal. Evidence for 
this connection is supported by studies which demonstrate that bi-
Lateral superior cervical gangli_onectomy rendered pineal HIOMT activity 
unable t.o respond Lo changes in the photoperiod (Wurtman et al., 1964; 
HeiLer and Sorrentino, 1971; Eichler arid Moore, 1971; Moore and Rapport, 
1971). Additional evidence _to demonstrate the existence of these tracts 
has been supplied by Moore and colleagues (1968) who demonstrated that 
destruction of the primary optic tracts at the level of the lateral 
geniculate bodies does not effect pineal HIOMT activity while destruc-
tion of the inferior accessory optic tracts within the medial forebrain 
bundle eliminates pineal HIOMT response to darkness. 
Physiological Effects of Photoperiod 
on Reproduction 
There are numerous physiological effects of photoperiod on the 
reproductive system. As early as 1894, Cook (N.Y.J. Obstet. Gynecol., 
editorial) reported that Eskimo women cease menstruation for 4 months 
during the long period of darkness in the winter months (Reiter et al., 
1975). More recent reports also confirm this early observation. Women 
wilh irregular menstrual cycles subjected to a period of constant light 
or· 3 to 4 days near the t i.me of ovulation resulted in menstrual flow in 
2 weeks (Dewan, 1967; Dewan and Rock, 1969). 
In Lhe adult female raL, long term exposure to constant light is 
known to produce the phenomenon known as persistent estrous (Browman, 
1937; Fiske, 1941; Daane and Parlow, 1971). This phenomenon is 
characterized by a chronic vaginal cornification, enlarged ovaries, 
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failure to ovulate, a slight elevation in LH and Follicle Stimulating 
Hormone (FSH) and presumably an increase in circulating estrogens. In 
the immature female rat, constant light accelerates puberty (Fiske, 
1941; Piacsek and Strcur, 1975); however, the younger the rat the longer 
it takes to observe the phenomenon of persistent estrous (Takeo et al., 
1975). 
The opposite effects on reproductive physiology are observed in 
rats exposed to either long dark periods or constant darkness. Fiske 
(1941) demonstrated that young female rats exposed to short photo-
period start estrous cycles at an older age. The effects of photo-
period on the estrous cycle seem to depend on the age and strain of 
the rat. Adult rats kept in continuous darkness for 80 days exhibited 
longer cycles with more diestrous smears (JHchle, 1956). Whereas, 
Wistar rats placed in constant darkness or blinded as adults will ex-
hibit complete anestrous in 20% of the cases (Hoffmann, 1969). 
Testicular atrophy has also been observed in response to a de-
creased photoperiod when prepubertal rats were used as an experimental 
model (He iter, 196 8; Takahashi et al. , 1971) . When rats are maintained 
on a short photoperiod of 2 hours of light daily and compared with rats 
maintained on a long photoperiod of 23 hours of day light, an 11% re-
duction in testis weight is observed in the rats on the short photo-
period (Kinson and Peat, 1971). This testicular hypotrophy disappears 
after 4 weeks while a decrease in prostate growth continued up to 7 
weeks. After 4 weeks of reduced lighting an 85% reduction in testo-
sterone from testicular venous blood was observed. 
The reproductive effects of alterations in the photoperiod can be 
nicely reversed by either pinealectomy or the administration of pineal 
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extracts. J~chle (1956) demonstrated that the administration of bovine 
pineal extracts to cycling female rats would prevent the persistent va-
ginal estrous produced by constant light. Furthermore, Wurtman and 
colleagues (196]) demonstrated that constant light and pinealectomy 
increased ovarian weights while rats in constant darkness exhibited 
smaLler ovaries. The increase in ovarian weight produced by constant 
light was prevented by bovine pineal extracts. It has also been re-
ported that pineal glands from rats maintained in constant light con-
tain no antireproductive material as these extracts failed to inhibit 
compensatory ovarian hypertrophy (COH) in mice (Reiter et al., 1975). 
This observation was supported by Hoffmann and Cullin (1975) who re-
ported that pinealectomy does not influence the persistent estrous 
induced by constant light. However, it should be noted that under 
normaL photopcriods, the pineal from day-killed rats is just as capable 
of reducing COil as that from night-killed rats (Heither et al., l975d). 
Thus, there is good evidence to suggest that the functional status of 
the pineal is at least partially dependent upon environmental light-
ing. This relationship as well as the relationship between lighting 
and reproductive physiology has led many to investigate the relation-
ship between the pineal gland and reproductive physiology. 
Antireproductive Properties of the 
Pineal Gland 
M<lst research concerning the antireproductive properties of the 
pineal gland has implicated either the gonads or the pituitary as target 
organs. Some researchers have reported a direct effect of the pineal 
gland on the pituitary. Thiebolt (1965) reported that pinealectomy 
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resuLted in an increase :in the number of pituitary basophils and pre-
sumably hyperactivity of the pituitary; however, others have reported 
no effect of pinealectomy on pituitary morphology (Wragg, 1967). Wurt-
man (l9S9) reported that pinealectomy caused a significant increase in 
pituitary weight while the administration of protein free bovine pineal 
extracts resulted tn a decrease in pituitary weight when compared to 
control animals. 
Indolamines 
Further examination has yielded fruitful information concerning 
the influence of the pineal gland or its extracts on the pituitary con-
tent and circulating levels of tropic hormones. Fraschini and col-
leagues (1968) found that pinealcctomy results in an increase in 
pjt.uitary LJ-1 content and presumably release as indicated by an increase 
in the weight of' the testis, ventral prostate and seminal vesicle. 
They also determined that implants of either pineal tissue or melatonin 
into the median eminence or midbrain reticular substance of castrate 
rats resulted in a reduction of pituitary LJ-1 stores. Melatonin was 
also found to reduce plasma LJ-1 levels. However, when this compound 
was implanted into the pituitary it was observed to have no effect on 
Lll. This was interpreted as indicating that pineal indoles modify 
pituitary function via the hypothalamus. Motta and colleagues (1967) 
also observed that high doses of melatonin signific~ntly reduced pros-
Late and seminal vesicle weight whi lc having no apparant affect on 
tcs ti s weight.. 
llcccnt evidence has also suggested that melatonin can affect 
gonadotropin secretion. In adult male rats, melatonin given in high 
]() 
doses subcutaneously f'or 6 days was f'ound to significantly reduce serum 
UI levels and decrease seminal vesicle and ventral prostate weight 
(Moguilevsky et al., 1976). They further demonstrated that simultane-
ous treatment with melatonin and clomiphene (a substance which is be-
lieved to stimulate the hypothalamus to release luteinizing hormone 
releasing hormone (LHH) resulted in an inhibitory effect on serum LH. 
They also found that melatonin given with exogenous LRH did not modify 
the pituitary's response to LIUI. This was interpreted as indicating 
that melatonin acts on the hypothelamus to inhibit LH release. How-
ever, the results from pituitary glands studied in organ culture indi-
cate that melatonin, serotonin, and 5-methoxytryptamine are capable of 
reducing the pituitary's response to LRH in vitro (Martinet al., 1977). 
The indoleamime 5-hydroxytryptophol has also been reported to decrease 
pituitary LH content (Fraschini et al., 1971). Interestingly, when ad-
ministered systemically, 5-hydroxytryptophol does not affect pituitary 
or serum LH levels. 
Apparently melatonin is able to affect only LH synthesis and re-
lease f'r·om the anterior pituitary (Heiter and Fraschini, 1969) while 
pincalcctomy has been shown to affect both LH and FSH (Fraschini, 
1969). Hccently, serotonin containing nerve cells associated with LRH 
production have been discovered in the arcuate and ventromedial nucleus 
(Smith and Kappers, 1975). The fact that pinealectomy reduced the 
number of serotonin containing neurons in these nuclei, coupled with 
the fact that serotonin inhibits both the synthesis and release of LRH 
in the hypothalamus (Moszkowska ct al., 1973), has led Smith and Kap-
pers (1975) to postulate that certain pineal compounds stimulate the 
11 
production of serotonin 1n neurons 1n the hypophysiotropic area of the 
hypothalamus which then inhibit the production of LRH. 
Although there seems to be much evidence that would suggest that 
melatonin 1s an antireproductive compound, several have suggested that 
melatonin 1s actually progonadotropic in the rat and hamster. Reiter 
and colleagues (l975a, l975b, l975c, l976a, l976b, l976c, l977a, 
l977b) have demonstrated that melatonin implants can reverse the ef-
fects of blinding and anosmia 1n both the hamster and the rat when 
given late 1n the photoperiod to an animal with an intact pineal. They 
found that melatonin restored the levels of both LH and prolactin that 
had been previously reduced by blinding and pinealectomy. It has also 
been reported that melatonin implants can block the inhibitory action 
of a partially purified pineal antigonadotropin on compensatory ovarian 
hypertrophy In mice (Orts ct al., l975a). Tamarkin et al. (1977) sug-
gested that exogenous melatonin may be either potentiated or inhibited 
by the presence of the pineal or its antireproductive compounds de-
pending on the time of injection. 
The indoleaminc melatonin is also known to directly affect the 
gonads. As early as 1963, Wurtman and colleagues (1963) found that 
microgram amounts of melatonin was capable of decreasing both ovarian 
weight and the incidence of estrus. They found that a single injec-
bon of me] a ton in decreased the incidence of estrus among rats exposed 
to constant light. However, others have not been able to find an ef-
fect of microgram quantities of melatonin in the immature or mature rat 
on gonadal weight or the estrous cycle (Ebcls and Prop, 1965). Inter-
estingly, they did find that melatonin would slightly reduce the light 
I~ 
induced depletion of lipids in the pineal. More recently, it has been 
determined that melatonin will selectively inhibit the incorporation of 
12 5 . t th . f t h . 1 t ff t . 12 5 . I-LH 1n o e ovar1es o ra s w 1 e no e ec 1ng I-FSH 1ncor-
poration into the ovaries (Trentini et al., 1976). This was interpreted 
as indicating that melatonin directly prevents the stimulatory action 
of LH on the ovary. 
Perhaps one of the most important effects of melatonin is the in-
hibition of the conversion of steroid precursors to androgens (Ellis, 
1969). It was determined that the conversion of androstenedione to 
testosterone was the point of indole interference. Apparently the in-
hibition by melatonin is mostly non,-eompetitive and involves the sup-
pression of 17 B-hydroxysteroid dehydrogenase, 17~-hydroxylase and 
C-17-C-20 lyase systems (Ellis, 1972). 
Unknown Peptides 
Other laboratories have reported the existence of several uni-
JcnLified pineal peptides. Benson and his colleagues (Benson et al., 
1971; Benson eL al., 1972) have demonstrated that a melatonin free 
cornpound(s) was significantly more potent than melatonin in blocking 
COil in mice. They have also demonstrated the ability of this com-
pound(s) to inhibit the postcastration rise in serum LH in the mature 
male rat (Orts et al., l974a), delay vaginal opening time and reduce 
the incidence of constant ertrus in female rats exposed to constant 
light (Orts et al., l974b). Orts and colleagues (Orts et al., l975b) 
have demonstrated the ability to these compound(s) to block pregnancy, 
reduce t:hc pre-ovulatory surge of LH (Orts et al., l977b) and reduce 
serum UI and testosterone in the male rat (Orts, l977a). Benson and 
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colleagues (Rosenblum et al., 1976; Benson et al., 1976) have reported 
a difference bclween AVT and their partially purified pineal extract, 
observed by both differential localization and chemical means. 
Others have reported the presence of pineal polypeptides with 
antireproductive properties. Ebels, Moszkowska and Scimama (1970) 
isolated a compound which inhibits in vitro the secretion of FSH from 
the anterior pituitary and also inhibits the hypophysiotropic hormones 
(Citharel et al., 1973). A somewhat similar extract of bovine pineals 
has also been isolated which inhibits ovulation that has been induced 
with pregnant mares serum (PMS) and human chorionic gonadotropin (HCG) 
(Ota cl al., 1975). 
While most of these putative pineal polypeptides have been demon~ 
strated to be free of the pineal indole melatonin, most have not 
demonstrated either the presence or absence of AVT in their extracts. 
Biochemical isolation and identification needs to be accomplished be-
fore any definitive statements can be made concerning the existence 
of several new pineal antigonadotropins. 
Arginine Vasotocin 
Identification, localization and release. Being the most 
ubiquitous and probably the oldest of the active neuropeptides, the 
octapeptide arginine vasotocin (AVT) is found in all major vertebrate 
groups from the cyclostomes to the mammals (Sawyer, 1968). This pep-
tide was first tentatively is6lated and identified in the bovine pineal 
using bioassays which take advantage of its pressor and oxytocic ac-
tivities (Milcu ct al., 1963). More specifically, these included the 
rat pressor, rat uterus, hen oxytocic and frog bladder bioassay. It 
was found that magneslum enhanced the oxytocic activity of this peptide 
while oxytocin had greater activity without magnesium. Based on this 
observation they determined the peptide they had isolated was not 
oxytocin. They also found extremely high frog bladder and hen oxytocic 
activity with low rat pressor and oxytocic potencies. This constituted 
good evidence the peptide was not arginine vasopressin (AVP). Chroma-
tography revealed a single spot with the same Hf value as AVT. Treat-
ment with trypsin was found to destroy the pineal peptide's biological 
activity, thus supplying additional evidence that the peptide was not 
oxytocin as oxytocin is unaffected by tryptic digestion. The existence 
of a disulfide bond in the pineal peptide was also demonstrated by re-
duction with sodium thioglycolate, which also inactivated the pressor 
and oxytocic activity. Based on these observations, Milcu and col-
leagues determined that the peptide was AVT. 
Using very similar biological and chemical assays, Pavel (1965) 
isolated a polypeptide from pig pineal glands with biological, enzy-
matic and chromatographic characteristics not significantly different 
from those of synthetic lysine vasotocin. The difference between bo-
VIne and porcine vasotocin is consistent with the fact that bovine 
neurohypophyseal extracts contain arginine vasopressin, whereas pig ex-
tracts contain lysine vasopressin. 
The biochemical isolation and characterization of AVT was finally 
accomplished in 1970 (Cheesman and Fariss, l970a; Cheesman, l970b). 
Using amino acid analysis and mass spectometry, AVT was jdentified in 
the bovine pineal glaml. 
Immunocytochemical evidence has also suggested the presence of a 
distinct population of cells in the rat pineal gland which contains AVT 
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(Howie and Herbert, 1976). These cells were found to be distributed 
di.ffuscly throughout the gland and appeared very irregular in form with 
extensive perivascular and intercellular processes. These processes 
were f'requen t ly found cupped around neighboring ce 11 s. 
Hadioimmunoassay data indicate that the pineal gland of the rat 
contains ~~.4 uU AVT/gland (Rosenbloom and Fisher, 1974, l975a, l975b). 
The rabbit subcommissural organ was also reported to have radioim-
munoassayable levels of AVT. Both the pineal and the subcommissural 
organ of the younger animal contains more AVT than the adult (Rosen-
bloom and Fisher, l975b). Recent observations using immunofluorescence 
techniques have also suggested the presence of AVT in the fetal pitui-
tary gland (Swaab et al., 1976). 
Subsequently, Pavel (1971) has attempted to identify the struc-
tures in the bovine pineal that contain this peptide. It was de-
termined that in the adult only the pineal stalk exhibited frog blad-
der activity while both the fetal stalk and gland exhibited high 
activity. Assuming that the frog bladder assay reflects the presence 
of AVT, activity is found only in those regions of the pineal that con-
tain secretory ependymal cells. Since the entire fetal pineal is 
formed by secretory ependymal cells whereas, in the adult the only 
ependymal cells are those found in the pineal stalk which constitutes 
the pineal recess of the third ventricle (Anderson, 1965), this would 
strongly suggest that AVT is liberated from the pineal by ependyma-
secretion. 
Fur·l.hcr investigations have confirmed the existence of AVT in the 
pineal glands of fetal, neonatal and adult male rats (Pavel et al., 
l975b). The AVT content of the male rat pineal markedly decreases from 
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the fetal to adult animal and was correlated with the regression of 
pineal secretory ependymal cells during development. Pavel has sub-
sequently isolated a polypeptide released from cultured pineal 
ependymal cells (rat fetuses aged 17 to 19 days post-coitum) that ex-
hibited hydroosmotic, antidiuretic and rat uterine activity that could 
not be distinguished from synthetic AVT (Pavel et al., 1977). Paper 
chromatography revealed Rf values (Hf 0.15-0.35) not significantly dif-
ferent from synthetic AVT but significantly different from the fast 
moving region corresponding to synthetic oxytocin (Rf 0.55-0.65) used 
as a standard. The total amount to AVT released from these cultured 
cells was about 40 times greater than the amount contained in non-
incubated pineal glands of the same age. This was interpreted as 
strongly suggesting de novo synthesis of AVT. 
Very similar results were seen when human fetal pineal glands 
(male, age 9~-115 days) were cultured (Pavel, l973a). The ratio of 
hydroosrnoLic t.o antidiuretic activity of the pineal peptide was found 
t.o be L81 with that of synthetic AVT to be 195. The hydroosmotic and 
antidiuretic activities were destroyed by tryptic digestion, oxidative 
inactivation by tryosinase and reductive inactivation by sodium thio-
glycollate. The total amount of AVT-like peptide released into the 
culture media was ten times greater than the amount contained in the 
nonincubated pineal glands of the same age. Again Pavel interpreted 
this as indicating de.~ synthesis of AVT. 
Several investigators have found evidence of a neurophysin-like 
protein in the pineal which is presumably associated with AVT. Heinhay 
and colleagues (L9711) found two neurophysin-like proteins in bovine 
pineal extracts. They appeared to be associated with a biologically 
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and immurwJogica1ly active ncuropcptidc similar to AVT. Suhsequenlly, 
Lcgr·os el aL. (\976) has also identified immunologically active neuro-
physin and AVT from human fetal pineal glands. However, the AVT was 
not attached to the neurophysin, suggest·ing a rapid enzymatic degrada-
tion of the precursor molecul~. 
A vasotocin-like peptide has also been identified in the cere-
brosp·inal fluid (CSF) of both humans and cats (Pavel, 1970; Pavel and 
Coeulescu, 1972). The biological activity of the CSF peptide differed 
significantly from those of the known human neurohypophysis (as assayed 
by antidiuretic, oxytocic and f~og bladder activities) but were not 
significantly different from synthetic AVT. In the cat, intraventri-
cular injections of 0.85 M NaCl stimulated the release of AVT into the 
third ventricle. The physiological significance of this remains to be 
elucidated. 
Pavel (l973b) has also demonstrated that injections of melatonin 
(100 ug/kg of body weight) into the third ventricle of cats or intra-
venous injections of melatonin (5 ug/kg body weight) stimulated the re-
Lease of a vasotocin-like peptide into the third ventricle. Melatonin 
by either route of administration had no effect on AVP or oxytocin re-
lease into lhe third ventricle. Pavel concluded that melatonin acts 
not as a neuroendocrine transducer, but as an intermediate step that 
facilitates AVT release. 
Along with melatonin and saline, Goldstein and Pavel (1977) have 
reported that LRH, thyrotropin releasing hormone (TRH) and somatotropin 
release inhibitory factor (SRIF) are capable of releasing AVT into the 
third ventricle of the cat when injected into the carotid artery. Oxyto-
cin and sal inc had no effect on AVT release when administered similarly. 
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Hccently, a diurnal rhythm of vasoloc i i1 has hccn r·cporl.cd in l.he 
male ral pineal (Calb et al., 1977). It was determined that the pineal 
content of AVT was highest at noon and lowest around midnight. They 
also determined that animals exposed to constant light contained a 
diminished pineal content of AVT while those exposed to constant dark 
had enhanced pineal AVT content. Pavel interpreted this as indicating 
a decrease in AVT synthesis with constant light and an increase in 
synthesis with constant dark. This was interpreted as indicating that 
AVT synthesis and release was enhanced during the night. 
Antireproductive Properties of Arginine Vasotocin j_n the Immature 
Animal. The physiological importance of AVT has been the subject of 
investigation in.only a few laboratories over the last decade. In 
1966, Pavel was one of the first to examine the antireproductive prop-
erties of synthetic AVT and to compare it with a peptide isolated from 
lhe pineal (Pavel and Petrescu, 1966). Immature female mice received 
PMS along with either a purified pineal peptide or synthetic AVT 
(subcutaneously) for three days and were necropsied on the fourth day. 
The data ucmonstrated that the stimulatory action of PMS on mice uteri 
and ovar1cs was inhibited by both the pineal peptide and synthetic AVT. 
Pavel concluded that the inhibitory principle from the bovihe pineal 
gland was identical to AVT and that both can directly effect the ova,ry. 
Based on this and similar research, several laboratories have in-
vestigated the importance of AVT in the immature animal. Vaughan and 
cc>llcagues (l976a) reported that single daily subcutaneous injections 
of' AVT on days one through five after birth resulted in significantly 
clcvaLeu lesl.is and accessory organ weights at 30 and 60 days of age. 
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By 90 days of age, the gonad and accessory organ weight in the control 
animals were equivalent to that of the AVT-treated groups. This was 
interpreted as indicating a possible early maturation of the 
hypothalamaco-hypophysial-gonadal axis after AVT injection, although 
this interpretation and experiment remains to be confirmed. 
In contrast, l ug AVT was injected daily for three consecutive 
days 1.n immature (25 day old) male mice. Upon autopsy 24 hours after 
the last Lnjection, growth of the ventral prostate, seminal vesicles 
and coagulating glands were significantly inhibited (Vaughan et al., 
l974b). 
The administration of AVT to PMS and/or HCG treated immature mice 
(Vaughan et al., 1976a; Vaughan et al., l976c) or immature rats (Smith 
et al., 1972) resulted in a decrease ip ovarian and uterine weights in 
the mice and a reduction in both the mean number of ova shed and the 
mean ovarian weight in the rat. AVT may also inhibit the growth of the 
gonads and accessory organs when immature animals are not challenged 
with exogenous gonadotropins (Vaughan et al., 1974a; Vaughan et al., 
l974b). 
In another experiment, Vaughan and colleagues (1975a) examined 
the time course of uterine and ovarian growth in the immature mouse 
after HCG stimulation and the effect of AVT on this stimulus. Female 
mice, 21 days old, received a single injection of 0.25 IU HCG intra-
peritoneally (IP). They were then divided into groups and each group 
received AVT (1 ug) at 0,12,24,36,48, and 60 hours post-HCG admini-
stration. Controls received Ringers lactate at the appropriate times. 
Representative animals from each group were necropsied at 0,12,24,36, 
48,60 and 72 hours. The results indicated a diurnal rhythm in 
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ovarian weight with HCG treatment. AVT treatment blocked this rhythm 
during the last 2 days. The initial increase in uterine weight was not 
blocked although latter phases of growth were significantly inhibited. 
Since a single injection of HCG causes estrogen release and 
uterine growth in the immature mouse within a few hours, these re-
sults were interpreted as indicaling that the action of AVT probably 
occurred at either the hypothalamus where it may modify LRH release or 
at the pituitary where it may modulate synthesis and/or release of the 
gonadotropins. This explanation was favored over a peripheral action 
of AVT because of its inability to block the initial growth of the 
ovaries and uteri. 
Hecently the effect of AVT on PMS induced ovulation in immature 
female rats has been studied in somewhat more detail (Johnson et al., 
1978). They found that if AVT is given every two hours beginning on 
the day preceding ovulation, the rise in plasma FSH is advanced and 
the magnitude of the LH peak is enhanced. However, there was a sig-
nificant inhibition of ovarian and uterine weights. This was in-
terpreted as indicating that AVT had a direct effect on the ovary. It 
was also found that if AVT is given to PMS-treated female rats which 
are then sacrificed prior to the afternoon surge of prolactin, a sig-
nificant elevation of prolactin is observed (Johnson, 1978). 
Antireproductive Properties of Arginine Vasotocin in the Mature 
Anim1tl. The administration of 2 ug AVT to pregnant mice resulted in 
delayed parturition and death of seven out of eight litters by the 
morning following delivery (Vaughan et al., l976a, l976b). The 
causative factors involved are not understood. Also, if AVT was 
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administered to normal cycling female mice, the estrous cycle was pro-
longed with the treated animals spending more time in diestrus. When 
paired with fertile males, these mice mated as soon as they came into 
estrus; however, AVT treatment inhibited fertile mating. Of those that 
became pregnant, all carried their litters to term and delivered as 
many pups per litter as the control animal (no injections were given 
during pregnancy). 
Moszkowska and Ebels (1968) incubated half-anterior pituitaries 
with synthetic AVT and the corresponding control halves with no treat-
ment. The resulting medium was then bioassayed for FSH. They found 
that both the medium incubated with AVT and the medium mixed with AVT 
after the incubation would result in a decrease in uterine weight. 
They interpreted this as indicating that AVT acts on the gonads or the 
gonadotropic hormone(s) and not on the secretion of the anterior hypo-
physis in vitro. 
It has also been demonstrated that AVT can inhibit COH in a dose 
related fashion in adult mice after intraperitoneal injection and 
after a single intraventricular injection (Vaughan et al., l976a). 
Heduction of the disulfide bond of AVT by mercaptoethanol not only 
destroyed AVT's ability to inhibit COH, but actually resulted 1n 
hypertrophied ovaries larger than the control animals. Along with AVT, 
the peptides AVP, oxytocin, 4-leucine vasotocin (4-leu-AVT), and 
lysine vasopressin (LVP) were tested for their ability to reduce COH 
in both their unreduced and reduced form. AVT, AVP, 4-leu-AVT, and 
I.VP in the unreduced form inhibited COH while AVT, AVP and LVP in the 
reduced form enhanced ovarian hypertrophy. Vaughan interpreted this 
as indicating that a basic amino acid in position 8 of the sidechain 
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and a closed disulfide bond are necessary for the antigonadotropic ac-
tivity while a basic sidechain (basic amino acid in position 8) and an 
open r1ng 1s progonadotropic. 
Pavel also examined the influence of AVT on COH in m1ce (Pavel et 
al., l973c). He found that 0.5 uU AVT administered into the third 
cerebral ventricle completely inhibited COH when measured 8 days later. 
Comparable results were found when 25 uU AVT were administered IV or 50 
uU (O.l ng) were given IP. From this, Pavel postulated that AVT in-
hibits COH by acting on gonadotropin(s) or on the synthesis or release 
of LHH. Similar results were seen when human fetal pineal extracts 
were administered to mice (Pavel el al., 1973/1974). They received 
0.5 ml of the extract IP and the results observed were identical with 
50 uU (0.0001 ug) of synthetic AVT in inhibiting COH. When compared 
to melatonin, 100 g of the indole was needed to inhibit COH to the 
same degree. Treatment of both human fetal pineal extracts and syn-
thetic AVT with trypsin, tyrosinase, and sodium thioglycollate com-
pletely destroyed their COH inhibitory effects. 
Pavel further reasoned that if AVT has a physiological significance 
1n inhibiting anterior pituitary hormones, it should be able to overcome 
the effects of pinealectomy; more specjfically on pituitary prolactin 
content as measured by the intradermal pigeon crop sac assay (Pavel et 
al., l975a). Ilc found that 0.0002 pg AVT (-120,000 molecules) injected 
into the third ventricle of the mouse, on the day of pinealectomy, pre-
vented the increase in pituitary prolactin which occurs 7 days after 
pinealectomy. This response appears .to be dose dependent as 2 pg AVT 
reduced the prolactin content below that of the sham-operated animals. 
This is believed to represent the lowest concentration reported so far 
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for a biological substance able to produce an endocrine effect. 
Because of the similarity between the terminal tripeptide of both 
AVT and LRH, several laboratories have investigated the possibility 
that AVT can competitively inhibit LRH receptor sites or stimulate LH 
release at the level of the pituitary. Vaughan and colleagues (1976a) 
found that LRH + AVT sighificantly augmented the accumulation of LH in 
the media of half anterior pituitaries (HAP) incubated for 5 hours when 
compared to their control halves. This seemingly progonadotropic re-
sponse is very difficult to explain. Possible explanations offered 
included the opening of the disulfide bond or the liberation of the 
terminal tripeptide. The terminal tripeptide (Pro-Arg-Gly (NH2 )) is 
known to potentiate the activity of FSH and LH on rat ovaries (De La 
Lastra et al., 1973). 
Using anterior pituitaries from intact male rats and estrogen-
progesterone primed female rats as models, it was determined (Vaughan 
ct. al., l975b) that both LH and prolactin were released from AVT treated 
half' anl.er·ior pi Lui taries into culture medium. The terminal tripeptide 
of' J\VT, l'ro-Arg-Gly (NH 2 ), failed to elicit a change in the release of 
I.H and prolactin. These results are very difficult to explain and the 
author only offers the explanation that high levels of prolactin are 
frequently found in cases of primary hypogonadism in human males and 
rats. 
The same laboratory has also demonstrated that the intravenous 
administration of AVT to either estrogen-progesterone or estrogen-
progesterone primed pinealectomized male rats will stimulate prolactin 
release .0_ vivo (Vaughan et al., l976d). This was accomplished in an 
acu!.e prepar·al.ion wit.h plasma levels of prolactin measured within 20 
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minutes of AVT administration. Based on this and the previous experi-
ment, the authors have proposed that AVT lS an extrahypothalamic pro-
lactin releasing factor. 
Subsequently, Blask and fellow researchers (1976) have observed 
that intravenous administration of AVT to estrogen-progesterone primed 
male rats will release prolactin 10 minutes after injection. They also 
observed that prolactin secretion from hemipituitaries incubated with 
haloperidol, propranolol or haloperidol plus AVT was unaffected (Blask 
ct al., 1977). However, if hemrpitui taries were incubated with pro-
pranolol plus AVT, a significant reduction in prolactin release was 
observed. This was jnterpreted as indicating that AVT has a B-
adl'energic type receptor on the lactotrophs of the anterior pituitary. 
In contrast, it was recently concluded that AVT does not effect 
the secretion of FSH or LH by rat anterior pituitary cells in a mono-
layer cell culture (Demoulin et al., 1973). They cultured anterior 
pituitary cells from 14 adult male rats in Dulbecco Modified Eagles 
Minimum l•:sscntial Medium,for 2 days. Synthetic AVT was then added in 
-7 -18 concentrations ranging from 10 to 10 M and the incubation was con-
l.inucd for three days, at which time the glands were washed and then 
incubaleu for another' 6 hours with AVT in the same concentrations, with 
or· without LH!l at a final concentration of 10-8 M. Their results 1n-
dicated that AVT effected neither the basal rate nor the LRH stimulated 
release of either gonadotropin. They further hypothesized that if AVT 
is involved in the regulation of gonadotropin secretion, the site of 
action is probably the hypothalamus. In agreement with this hypothesis, 
Vaughan (1978) demonstrated that AVT was capable of blocking the post-
castration rise of serum Lll and FSH. She also determined, using a 
bioassay, that the hypothalami from the AVT treated rats contained 
significantly more LHH. 
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Others have found that AVT, when given intravenously to unanesthe-
sized proestrus rats at a rate of 1.0 ug/hour for 3 hours, was capable 
of suppressing the preovulatory surge of LH and prolactin but had no 
effect on the concurrent surge of FSH (Cheesman et al., l977a, l977b). 
Furthermore, they found no effect on the tonic level of any of the 
aforementioned hormones. Addition~lly, it was found that ovulation 
was also inhibited in those animals treated with AVT. Investigating 
the mechanisms involved, they determined that picogram quantities of 
AVT injected intraventricularly will eliminate the preovulatory surge 
of LH in 33% of the rats (Osland et al., 1977). AVT was also found to 
have no effect on the prostaglandin E2 (PGE 2 )-induced release of LH or 
the LH release associated with the electrochemically stimulated medial 
preoptic area. They concluded that AVT probably inhibits the LH surge 
at the medial preoptic level or higher centers. 
Summarizing the data just presented proves to be a difficult task. 
There appears to be two major theories concerning the release of AVT. 
It would appear that Pavel and his colleagues believe that AVT is most 
important in the fetal animal. He has demonstrated that AVT is syn-
thesized in the fetal pineal gland and is secreted from the pineal 
gland by ependymal secretory cells into the third ventricle. In the 
adult, he has demonstrated its existence only in the pineal stalk. 
After AVT enters into the CSF, it then exhibits an effect on the hy-
pothalamus or pituitary leading ultimately to one of several anti-
reproductive responses such as inhibiting COH or uterine weight. He 
has suggested Lhal AVT might stimulate prolactin release. 
The second theory may be attributed to Reiter and colleagues 
(l976e). They postulate that the pineal polypeptides are secreted by 
pineal sccrel.ory eel is--which may be either pincalocytes, glial cells 
or ncur·ons--conjugated to carrier proteins in much the same way that 
vasopressin and oxytocin are bound to neurophysin I and II. These 
peptides are exocytotically extruded into the extracellular space 
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along with considerable exocytotic debris. In a method similar to that 
of the posterior pituitary, the blood Ca++ is then exchanged with the 
polypeptide hormone resulting in the release of the hormone into the 
blood stream. The by-products of this process, the carrier protein 
complex and the exocytotic debris then calcify and form the commonly 
known corpora arenacea or pineal sand. Once into the blood stream the 
peptide can then exhibit its antircpruductive properties. They have 
p<>stulated that one of these properties is affecting the release of 
prolactin from the pituitary, thus qualifying AVT as an extrahypothala-
mic prolactin releasing factor. According to the same group of re-
searchers, AVT also appears to affect both the gonads and the 
hypothalamus. 
There is evidence to support both theories of AVT secretion. 
Whichever the case, it appears that once secreted, AVT can affect 
several levels of the hypothalamic-pituitary-gonadal axis. 
CHAPTER III 
MATERIALS AND METHODS 
In order to determine if AVT has an effect on reproductive endo-
crinology, three different experimental approaches were used in this 
study. They included the in vivo administration of the peptide, an-
terior pituitary incubations and pituitary homopenate uptake of 
L25 . th b f I-LRH In c presence or a sence o AVT. The parameters observed 
in the first two experimental approaches were cpanges in LH and pro-
lactin concentrations. The response observed in the last approach 
125 was the ability of pituitary tissue to take up · I-LRH. 
Animals 
The animals used in this experiment were of the Sprague-Dawley 
strain and were Charles River's CD rats obtained from Charles ~iver, 
Tnc. They were maintained in the Oklahoma State University facilities 
in an ambient temperature of 23°C and in a diurnal lighting of 14 hours 
light and 10 hours dark (14L:lOD) with the daily photoperoid beginning 
of 0800 hours. All animals received food and water ad libitum. 
The castrate rats used in the pituitary incubations experiments 
were castrated at 35 days of age while the castrate rats used in the 
125 I-LHH uptake experiments were castrated at 28 days of age. All 
castrate rats were allowed 30 days to recover from the surgery. All 
surgery was performed under aseptic conditions using ether anesthesia. 
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Those castrate male rats receiving estrogen-pro~esterone {~-Pl 
priming t'tTcivcd one injel'l.ion of' tiH' steroids suhcul.ancousl.v 7:~ hour·s 
I '''1 
prior to l.hc i ncuha l. ions or· l.hc ~· 1-LHI! uptake s l.ud i cs. J•:ach rat. t'e-
ceived 50 ug l7B-estradiol {Sigma, No. E-8875l and 25 mg progesterone 
(Sigma, No. 95C-0320l in 0.5cc corn oil as a vehicle. This is a modi-
fication of Hamirez and McCann {l963l method for estrogen-progesterone 
priming rats for testing LRH releasing activity. 
In Vivo Administration of Peptide 
Th i rl.y male rats 115 days of age, were utilized in this experi-
ment and were divided into 5 equal groups. Rats 1n groups A and B 
received 0.1 ml of saline at 1100 hours each day for 5 days. Groups 
C, U and J•: received O.l, l.O or 10.0 ug AVT, respectively. The AVT 
was administered in 0.1 cc of saline at 1100 hours each day for 5 days. 
In all cases the diluent and the AVT were injected subcutaneously. 
On the sixth day of the experiment, the rats were anesthetized 
with urethane (78 mg/100 g bwl given intraperitoneally. The right 
jugular vein was then exposed and cannulated with "intramedic" poly-
ethylene tubing P.E. 50 {T.D. 0.023", O.D. 0.038"l which was pre-
viously J'il led wil.h heparinized (50 units/eel saline. The rats were 
packed with moist. gauze and kept warm throughout the experiment. 
At 1100 hours a pre-injection {time 0 l blood sample was collected 
from each rat. Immediately thereafter, the rats in Groups B, C, D and 
l•: received 100 ng LHH in 0.1 cc of saline through the venous catheter 
which was then rinsed with 1 cc of.heparinized (10 units/eel saline. 
Hats in Group A received 0.1 cc of saline containing no LRH. Addi-
tional blood samples from each animal were collected at 30, 60, 120 
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and 180 minutes post-injection. The samples of 30, 60 and 120 minutes 
were collected by the venous catheter while the 180 minutes samples 
were collected by decapitation. After all but the final blood sample, 
1 cc of heparinized (10 units/cc) saline was added as a volume re-
placement. All blood samples were then centrifuged, the plasma col-
lected frozen at -20°C until analyzed for LH and prolactin. 
Pituitary Incubations 
A modification of the procedure developed by Mittler and Meites 
(1966) for pituitary incubations was used for all experiments. The 
rats were lightly anesthesized with ether and decapitated. The skull 
cap and brain were removed exposing the pituitary gland. Upon removal 
of the pituitary gland, the posterior lobe was dissec~~d Prom the an-
terior lobe and discarded. The anterior pituitary was then hemi-
sectioned with each of the half anterior pituitaries (HAP) weighed 
and immediately placed into separate incubation flasks. Each flask 
had been previously coated with 1% bovine serum albumin (BSA) in 
phosphate buffered saline (PBS) and contained 2 ml of incubation media 
consisting of Krebs-Ringer bicarbonate with 200 mg percent glucose 
(KRBG, Appendix A). The HAP were then preincubated for 30 minutes at 
the end of which each HAP was removed and placed into a fresh BSA-
coated flask containing 2 ml of media. The HAP were then incubated 
for either 4 or 6 hours with gassing every 30 minutes with 95% 
o2-5% co2• Both preincubation and incubation were performed at 37°C 
with continuous shaking (American Optical Water Bath Shaker) at a rate 
of 60 cycles per minute. After termination of the incubation both the 
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incubation media and aqueous extracts of the HAP were stored frozen at 
-20°C until assayed for LH or prolactin. 
Using this procedure, one HAP served as a control and was incu-
bated with KHBG containing varying concentrations of LRH. The cor-
responding HAP then served as experimental tissue and was incubated 
with KRBG and LRH along with varying concentrations of AVT. (Appendix 
B describes the LRH and AVT in more detail). Anterior pituitaries from 
rats under various steroid environments were utilized for the pituitary 
incubations. 
Pituitary Incubation I 
In this experiment the HAP utilized were obtained from either 100 
day old intact male or 100 day old estrogen-progesterone primed cas-
trate male rats. In either case, the 6 control HAP received no treat-
ment while their corresponding halves were incubated with 1 ng/ml LRH. 
Each HAP was incubated for 6 hours. 
Pituitary Incubation II 
Intact male rats 100 days of age served as pituitary donors in 
this experiment. The HAP from each of ten animals were incubated in 
each of 4 treatment groups. All HAP were incubated with 1 ng/ml LRH 
while the media of the experimental halves also contained AVT in log 
concentrations from 0.01 to 10 ng/ml. The experiment was terminated 
after 6 hours. 
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Pituitary Incubation III 
Pituitaries were obtained from 125 day old intact male rats. Six 
pairs of HAP were incubated in each treatment group. All HAP were in-
cubated with lO ng/ml LHH while the experiment HAP were also incubated 
with 1,10 or 100 ng/ml AVT in their incubation media. The pituitaries 
were incubated for 6 hours. 
Pituitary Incubation IV 
In this experiment castrated male rats served as pituitary donors. 
All rats were 60 days of age upon sacrifice. The control HAP were in-
cubated with 1 ng/ml LHH while the corresponding halves were incubated 
with 1 ng/ml LRH and log concentrations of AVT ranging from 0.1 to 100 
ng/ml. There were 6 pairs of HAP per treatment group. After 4 hours 
of incubation the experiment was terminated. 
Pituitary Incubation V 
The design of this experiment was the same as that of pituitary 
incubation IV except that estrogen-progesterone primed castrate male 
rats served as pituitary donors. 
Pituitary Incubation VI 
Intact female rats 100 days of age served as pituitary donors. 
These ratp served as donors regardless of the stage of the estrous 
cycle. All HAP were incubated with 1 ng/ml LHH while the experimental 
halves were also incubated with log concentrations of AVT ranging from 
1 to 1000 ng/ml. Five pairs of HAP were incubated in each treatment 
group. All HAP were incubated for 6 hours. 
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Pituitary Incubation VII 
In this experiment 10 intact female rats 100 days of age in 
various stages of the estrous cycle served as pituitary donors. Control 
HAP were incubated in media with the experimental HAP also incubated 
with 1 ng/ml AVT. All pituitaries were incubated for 6 hours. 
Pituitary Incubation VIII 
Ten intact male rats 100 days of age served as pituitary donors 
1n this experiment. All HAP were incubated with l ng/ml LRH. The 
experimental halves were also incubated with l ng/ml AVP. In the 
second part of this experiment, 10 intact male rats of the same age as 
those previously discussed served as pituitary donors. Control HAP 
were incubated in media only while experimental halves were incubated 
with l ng/ml AVP. All pituitaries in this experiment were incubated 
for 6 hours. 
Pituitary Homogenate Uptake 
of 125 I-LRH 
h b .l. f t ff t th t k f 125 H . "t "t T e a 1 tty o AVT o a ec e up a e o I-LR ln a pl Ul ary 
homogenate was examined in both intact male and estrogen-progesterone 
primed castrate male rats using the techniques of Pedroza et al. (1977). 
All rats utjJized were 60 days of age. The rats were lightly anesthe-
sized with ether and rapidly decapitated. The anterior pituitaries 
were collected, pooled and homogenjzed in Hepes buffer (Sigma, No. H-
3375) (pH 7.2) wilh 0.5 mg/ml Haetracin (Sigma, No. B-0125). The 
homogenate was then placed into tub~s such that each tube contained 
33 
the equivalent of one pituitary in 0.5 ml of buffer. The tubes also 
contained varying concentrations of LHH or AVT ranging from 1 to 1000 
mM i.n 10 ul of buffer. 125 Each tube also contained 4.5 nM I-LRH (440 
uCi/ug) in 25 ul of buffer. The LRH was iodinated using the lacto-
peroxidase method of Nett et al. (1973). Tubes without pituitary 
homogenate but containing 535 ul buffer s~rved as blanks. All tubes 
were allowed to incubate for 30 minutes at 4°C. The incubation was 
stopped by centrifugation at 7500 rpm for 15 minutes at 4°C. The 
pellet of homogenate was washed 2 times with Hepes buffer and radio-
activity of the pellet was counted in a gamma counter (Nuclear-
Chicago). All values were corrected by substracting blank values. 
Radioimmunoassay of LH and Prolactin 
The radioimmunoassay (RIA) of rat LH was performed in duplicate by 
the double antibody RIA procedure as described by Niswender et al. 
(1968). The anti-LH antibody (anti-ovine LH antibody, pool No. 15) was 
kindly supplied by Dr. G. Niswender. The purified LH for iodination 
(LH I-4) was supplied by Dr. A. F. Parlow through the NIAMD Rat 
Pituitary Hormone Distribution Program. The LH concentrations were ex-
pressed in terms of NIAMD Rat LH RP-1 having a biological potency of 
0.03 x NIH LH-Sl (OAAD assay). The assay was determined to have a with-
in assay variation of 7.5% and a between assay variation of 10.3% (Ap-
pendix C contains parallel inhibition curves for LH RIA). 
The RIA for rat prolactin was performed in duplicate using the 
double antibody RIA procedure as described by the NIAMD rat prolactin 
kit provided by the NIH Hat Pituitary Hormone Distribution Program. 
The anti.scrum uti.lized was NIAMD anti-rat prolactin S-4 while the 
34 
antigen for iodination provided was NIAMD rat prolactin I-2. The pro-
lactin concentrations were expressed in terms of NIAMD rat prolactin 
IIP-L with a biological potency of 11 IU/mg (mouse deciduoma assay). 
The assay was determined to have a within assay variation of 6.8% and 
a between assay variation of 18.4%. (Appendix D contains parallel 
inhibition curves for prolactin RIA). 
The RIA for both LH and prolactin were determined from incubation 
media which had been previously diluted with phosphate buffered saline 
(PBS, pH 7.4). The results of all assays were calculated on a pro-
grariunable Ollivete P652 computer. This computer was programmed to 
construct a standard curve directly from the assay standards and also 
to correct the data for non-specific binding. 
Enzyme Determination 
In order to determine the viability of the· HAP after incubation, 
enzyme analysis was performed with "Dow Diagnostic Kit" for serum 
glutamic oxalacetic transaminase (GOT). This test is based on ultra-
violet spectral detection of NADH changes which are proportional to 
GOT activity (Amador and Wacker, 1962). Media from anterior pitui-
taries that were incubated for 2, 4, or 6 hours with oxygen were com-
pared as well as media incubated for 6 hours without oxygen. 
Histologi~al Preparations 
In order to determine the amount of cellular degeneration after 
incubation, the HAP were fixed in 10 percent buffered formalin for at 
least 48 hours. They were subsequently embedded, sectioned and 
stained with hematoxylin-eosin. Two HAP that were incubated for 6 
35 
hours without oxygen and to fresh pituitary tissue. Parameters 
examined included lhc appearance of nucleus and connective tissue 
stroma. 
Statistical Analysis 
The pituitary incubation experiments were analyzed using the 
paired t-test (Batson, 1956). This test measures the variance of the 
mean differences. The t value was then calculated as the mean dif-
ference divided by the standard error. The in vivo administration of 
pcptides experiment was analyzed using the one-way analysis of 
var i.ancc, the Newman-Keul test and the paired t-test (Steele and Tor-
rie, 1960; Zivin and Bartko, 1976). All hormone values are expressed 
as mean + standard error. 
125 
The I-LRH uptake studies were analyzed 
using the one-way analysis of variance and the student t-test (Steele 
and Torrie, 1960). 
CHAPTER IV 
RESULTS 
Enzymatic and Histological Determinations 
The results of the GOT assay as depicted in Figure 1 indicate a 
gradual but non-significant release of the enzyme from the anterior 
pi.luitary over the 6 hour incubation period. In contrast, when HAP 
were incubated for 6 hours under the same conditions without oxygen, a 
much larger release of GOT was observed. When comparing the GOT levels 
after 6 hours of incubation, the enzyme levels more than doubled 1n the 
media from those glands incubated without oxygen. 
The results of the histological examination indicate that the in-
tegrity of incubated pituitary tissue does differ from that of freshly 
fixed tlssue (Table I). However, significantly P < .001) more pyknotic 
nuclei and loose connective tissue were observed in those glands in-
cubated for 6 hours without oxygen when compared to those incubated for 
6 hours with oxygen. 
In Vivo Administration of Peptide 
Table II illustrates the in vivo effect of LRH and AVT on LH re-
lease. The only significant effect observed at time 0 was with group 
C. These rats contained significantly (P < .05) less LH than those in 
group B. The initial withdrawal of blood from the rats in group A 








































Fi_gure 1. Enzyme Analysis of Media From Rat Half 
Anterior Pituitaries Incubated With 
and Without Oxygen. (n = 3) 
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TABLE I 
111STOLOGICAL COMPAHISON OF RAT PITUITAHY TISSUE 
INCUBATED IN THE PHESENCE OH ABSENCE OF bXYGEN 
WITH FHESH TISSUE 
38 
Treatment Number of Pyknotic Nuc1ei1 
Fresh 
Incubated with oxygen 
Incubated without oxygen 
6 + 1 
18 + 12 
270 + 23 2 ' 3 
1Number of pyknotic nuclei observed in a 10 x 10 grid at X430 
power, mean~ S.E. (n = 3). 
2significantly (P < .001) more pyknotic nuclei than in fresh 
ti_ssue. 
3significant1y (P < .001) more pyknotic nuclei than in tissue 










EFFECT OF IN VIVO ADMINISTRATION OF AVT ON LRH STIMULATED LH RELEASE IN MALE RATS ---
GROUP 
A B -c- D E 
AVT (ug) 
0 0 0.1 1 10 
LRH (100 ng) 
11 + 22 15 + 4 7 + 1 6 13 + 3 10 + 2 - - - - -
89 + 37 632 + 114 7 ' 9 500 + 1017 ' 9 384 + 1137 ' 8 357 + 66 8 - - - -
37 + 96 86 + 78 56+56,10. 48 + 156 58 + 9 9 - - - - -
16 + 4 23 + 4 34 + 15 20 + 6 18 + 28 - - - - -









TABLE II (Continued) 
1Time after LRH administration. 
2 Expressed as ng/ml (n = 6), mean+ S.E. 
3Probability < .005 that all means are from the same population. 
4Probability < .010 that all means are from the same population. 
5Probability < .025 that all means are from the same population. 
6significantly (P < • 05) less than group B. 
7significantly (P < .05) greater than group A. 
8significantly (P < .05) greater than time 0 sample. 
9significantly (P < .01) greater than time 0 sample. 
10significantly (P < .001) greater than time 0 sample. 




significant increase in LH at both 30 and 60 minutes. These values 
returned to basal levels by 120 minutes where they remained until 
termination of the experiment. Serum LH values of the rats in group B 
(those receiving LRH only) significantly (P < .01) increased from a 
pre-injection nadir of 15 ! 4 ng/ml at time 0 to a zenith of 632 + 114 
ng/ml within 30 minutes after the ~dministration of LRH. This consti-
tutes over a 40 fold increase in LH. These values were still signifi-
eanLly (P < .05) elevated at 60 minutes but returned to basal levels 
by 120 minutes. Similar results were observed in groups C, D arid E 
(those rats receiving 0.1, land 10 ug AVT per day, respectively). 
Significant increases were observed 1n these groups within 30 minutes 
after the administration of LRH. These values remained elevated at 60 
minutes but returned to basal levels by either 120 6r 180 minutes. 
powever, when the degree of responsiveness to LRH was compared 
among.thc various treatment groups, a decrease in LRH stimulated LH re-
lease was observed in those groups that received AVT. Those animals 
rcecivi?g the greater amount of AVT exhibited the smallest response of 
LIUI-induced LH release. At 30 minutes, group E ( 10 ug AVT per day) was 
the only treatment group not releasing significantly more LH than 
group A. Groups B, C and D all released significantly (P < 0.05) more 
LH than did those in group A. A similar pattern of LH release was ob-
served at 60 minutes. Significantly (P < 0.05) less LH was observed 
in groups C and D when compared to group B. The LH values in groups C 
and D returned to basal levels by 120 minutes while group E returned 
to basal Levels at l80 minutes. 
The effect of AVT on prolactin release in this experiment is sum-
marized in Table III. No significant effect on prolactin release was 
TABLE III 
EFFECT OF IN VIVO ADMINISTRATION OF AVT ON PROLACTIN RELEASE IN MALE RATS 
GROUP 
A B c D E 
AVT (ug) 
Time 
0 0 0.1 1 10 
LRH (100 ng) 
0 30 + 31 30 + 3 36 + 7 37 + 6 27 + 4 -
30 45 + 6 37 + 1 35 + 3 49 + 8 58 + 22 - - - - -
60 39 + 2 40 + 5 32 + 3 45 + 4 51 + 9 - - -
120 35.+ 5 39 + 6 45 + 7 31 + 3 44 + 8 - - - -
180 36 + 4 31 + 3 31 + 7 42 + 10 35 + 1 -
1 
Expressed as ng/ml (n = 6), mean~ S.E. 










observed at time 0. In group A, the initial withdrawal of blood re-
sulted in a slight but non-significant increase in prolactin release at 
;)0 minutes which returned to basal levels by 60 minutes. A similar re-
sponse was observed in treatment group E Where a slight but non-
significant increase was observed at 30, 60 and 120 minutes. No effect 
of LIUI on prolactin release was observed 1n group B. In groups C, D 
and E AVT had no affect on prolactin release. 
Pituitary Incubations 
Pituitary Incubation I 
The results of pituitary incubation I demonstrate the ability of 
LHII to release LH from HAP. This data indicates that 1 ng/ml LRH sig-
nificantly released LH from anterior pituitaries taken from both ln-
Lact (P < .01) and estrogen-progesterone primed castrate male 
(P < .02) rats (Tables IV and VI). Interestingly, LRH also signifi-
cantly (P < .05) released prolactin from estrogen-progesterone primed 
castrate male rat pituitaries but not from the intact male HAP (Table 
IV and Table VI). In the intact male HAP, glandular concentrations of 
both LH and prolactin were unaffected by LRH (Table V). The LH con-
centration in HAP taken from estrogen-progesterone primed castrate 
male rats was significantly (P < .001) reduced (Table VII). The pro-
lactin concentration in IIAP from these rats was unaffected (Table VII). 
Pituitary Incubation II 
Pituitary incubation II examined the effect of logrithmic doses 




EFFECT OF LRH ON LH AND PROLACTIN RELEASE 
FROM INTACT MALE HALF ANTERIOR 
PITUITARIES 
1.98 + 0.37 
3.32 + 0.523 
1Expressed ln ug/ml media/mg HAP, mean+ S.E. (n 6). 
2 
1 ng/ml. 




l•:FFJ<:CT OF LHI! ON LH AND PROLACTIN CONCENTRATIONS 
OF INTACT MALE HALF ANTERIOH 
PITUITAHIES 
17.63 + 4.15 
18.09 + 2.40 





0.87 + 0.18 
1.07 + 0.26 
Prolactin1 
0.85 + 0.21 
0.74 + 0.15 
TABLE VI 
Jo:Fflo:CT OF LRH ON LH AND PROLACTIN RELEASE FROM 
ESTROGEN-PROGESTERONE PRIMED CASTRATE 
MAU: HAT HALF ANTimiOH PITUITAIUES 
Treatment LHl 
Control 7.96 + 1.81 
LRH2 
-
13.82 + 1.543 -






EFFECT OF LHH ON LH AND.PROLACTIN CONCENTRATIONS 
OF ESTHOGEN-PROGESTERONE PRIMED CASTRATE 
MALE HAT HALF ANTEHIOR PITUITARIES 
Treatment 
Control 161.99 + 25.62 
107.94 + 20.463 
l d J•:xpresse in ug/mg HAP, mean + S.E. (n 6). 
2 
1 ng/ml. 




0.53 + 0.06 
0.76 + 0.10 4 
Prolactin1 
3.27 + 0.46 
2.15 + 0.23 
46 
release and prolactin release from HAP taken from intact male rats. 
As indicated in Figure 2, AVT was observed to have no significant ef-
fect on LRH stimulated LH release. Similarly, AVT was found to have no 
significant effect on prolactin release from these HAP (Figure 3). 
Table VIII depicts the corresponding LH and prolactin concentra-
tion of HAP after incubation. In the group of HAP incubated with 0.01 
ng/ml AVT, a significant (P < .05) reduction 1n immunoassayable LH was 
observed. However, at higher concentrations of AVT no significant ef-
fect was observed although the data would indicate a similar trend. 
In contrast, a significant (P < .02) increase in prolactin concentra-
tion was observed in those glands incubated with 0.01, 0.1 and 1 ng/ml 
AVT (Table VIII). 
Pituitary Incubation III 
Results similar to those in pituitary incubation II were observed 
when the concentration of LRH 1n the incubation media was increased to 
10 ng/ml. AVT was without effect on LRH stimulated LH release.(Figure 
4). Prolact_in was also unaffected by the AVT concentrations utilized 
Ln this experiment (Figure 5). 
Gland concentrations of LH after incubation were not significantly 
affected by the AVT treatment (although the HAP incubated with AVT all 
contained less LH (Table IX)). However, the prolactin concentrations of 
HAP incubated with 10 ng/ml AVT were significantly (P < .02) reduced 
(Table IX). 
Pituitary Incubation IV 













































Vigure 2. Effect of AVT on LRH Stimulated LH Released Into 
Media From Ititact Male Rat Half Anterior 
Pi lui taries. All HAP treated with 1 ng/ml 
LHH whjle cross-hatching indicates those also 
incubated with AVT. Expressed as mean + S.E. 


















































Figure 3. Effect of AVT on Prolactin Released Into Media From 
Intact Male Hat Half Anterior Pituitaries. Cross-
hatching indicates those l~P incubated with AVT. 




EFFECT OF AVT ON LH AND PROLACTIN CONCENTRATIONS OF 
LRH STIMULATED HALF ANTERIOR PITUITARIES 
FROM INTACT MALE RATS 
Treatment 2 LHl Prolactin 
1 
LHH 18.26 + 2.58 0.71 + 0.12 
0.01 ng/ml AVT 13.79 + 1. 773 0.98 - 0.084 LIUI + + 
LRH 18.90 + 4.31 0.82 + 0.14 
ng/ml AVT 16.03 1.09 - 0.194 LRH + 0.1 + 2.92 + -
LRH 21.37 + 2.29 0.73 + 0.13 
1 ng/ml 19.62 - 1.15 - o.o94 LHH + AVT + 3.22 + - -
LHH 17.42 + 2.39 0.97 + 0.24 
LHH + 10 ng/ml AVT 14.65 + 1.90 0.90 + 0.14 
f 1Expressed ln ug/mg HAP, mean+ S.E. (n = 10). 
2 All HAP treated with 1 ng/ml LHH alone or with indicated concen-
trations of AVT. 
3p < .05 vs. corresponding control. 





































1 10 100 
ARGININE VASOTOCIN 
ng I ml 
¥igure 4. Effect of AVT on Ulli Stimulated LH Released 
Into Media From Intact Male Rat Half 
Anterior Pituitaries. All HAP treated 
with 10 ng/ml LRH while cross-hatching 
indicates those also incubated with AVT. 













































1 10 100 
ARGININE VASOTOCIN 
ngjml 
Figure 5. Effect of AVT on Prolactin Heleased Into Media 
From Intact Male Hat Half Anterior Pitui-
taries. Cross-hatching indicates those 
HAP incubated with AVT. Expressed as mean 
+ S.E. (n-= 6). 
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TABU: IX 
EFFECT OF AVT ON LH AND PROLACTIN CONCENTRATIONS 
OF LRH STIMULATED HALF ANTERIOR PITUITARIES 
FROM INTACT MALE RATS 
Treatment 2 LHl 
LHH. 24.64 + 5.41 
LHH + 1 ng/ml AVT 22.52 + 6.72 
LHH 20.42 + 5.47 
LJUI + 10 ng/ml AVT 18.67 + 3.98 
LHH 25.97 + 6.12 
LHH + 100 ng/m1 AVT 19.91 + 3.57 
52 
Prolactin 1 
1.55 + 0.28 
1.51 + 0.26 
2.03 + 0.09 - O.lo3 1.61 + 
1.46 + 0.33 -1.02 + 0.08 -
1Expressed 1n ug/mg HAP, mean+ S.E. (n = 6). 
2 All HAP treated with 10 ng/ml LRH alone or with the indicated 
concentrations of AVT. 
3P < .02 vs. corresponding control. 
53 
steroids on the influence of AVT on LH and prolactin were examined. The 
results of this experiment were similar to those observed in the intact 
male rat.. rt wa~ dcl:erminedthat AVT in log doses from 0.1 to 100 ng/ml 
had no eiTcct; on Lhc LHII stimulated Lll release from pituitaries obtained 
f'rom cas tratc male rats ( I;igure 6). AVT was also observed to have no 
effect on prolactin release in this experiment (Figure 7). 
In contrast, the HAP incubated with LRH and 0.1 ng/ml AVT were ob-
served to contain significantly (P < .01) less LH than the correspond-
ing halves incubated with LRH (Table X). The LRH-treated HAP receiving 
1, 10 and 1.00 ng/ml AVT also contained less LH although this difference 
wa~ not stat-istically significant. The HAP treated with 0.1 or 100 
ng/ml AVT were also observed to contain signi fi.cantly (P < .05 and 
P < .01, respectively) more prolactin than their corresponding control 
halves (Table X). 
Pituitary Incubation v 
In this experiment, the effect of AVT on LH and prolactin was 
examined in an animal model known to be sensitive to LRH. It was 
found that AVT in concentrations of 0.1 and 10 ng/ml was observed to 
significantly (P < .01 and P < .05, respectively) reduce the LRH 
stimulated LH release when compared to the corresponding control 
halves (Figure 8). A non-significant reduction of LH release was also 
observed at 1 and 100 ng/ml AVT. As with the previou~ incubations, 
AVT was found to have no significant effect on prolactin release in 
this animal model (Figure 9). 
Although no statistically significant reduction in gland LH con-


































1 10 100 
ARGININE VASOTOCIN 
ng 1 ml 
Figun: 6. I·:f'fect of AVT on LHH Stimulated LII Released Into Media 
From Castrate Male Rat Half Anterior Pituitaries. 
All HAP treated with 1 ng/ml LRH while cross-
hatching indicates those also incubated with AVT.· 












































0.1 1 10 
ARGININE VASOTOCIN 
ng 1 ml 
100 
Figure 7. Effect of AVT on Prolactin Heleased Into Media From 
Castrate !\'!ale Rat Half Anterior Pituitaries. 
Cross-hatching indicates those HAP incubated 




um + 0.1 
LRH 
TABLE X 
EFFECT OF AVT ON LH AND PROLACTIN CONCENTRATIONS 
OF LRH STIMULATED HALF ANTERIOR PITUITARIES 
FROM CASTRATE MALE RATS 
LHl 
103.97 + 4.95 
ng/ml AVT 65.92 - 6.823 + 
91.91 + 4.87 -Lim + 1 ng/ml AVT 87.58 + 9.89 
LHH 96.60 + 6.68 -LRH + 10 ng/ml AVT 79.50 + 8.75 
LHH 105.82 + 8.06 -LHH + 100 ng/ml AVT 97.03 + 7.05 -
56 
Prolactin 1 
0.83 + 0.08 
1.09 + O.ll4 -
1.33 + 0.32 -1.71 + 0.32 -
1.55 + 0.15 
1.31 + 0.17 
1.21 + 0.19 
1.56 + 0.213 
1Expressed in ug/mg HAP, mean_: S.E. (n = 6). 
2 All HAP treated with 1 ng/ml LRH alone or with the indicated 
concentrations of AVT. 
vs. corresponding control. 








































~igure 8. Effect of AVT on LRH Stimulated LH Released Into Media 
From Estrogen-Progesterone Primed Castrate Male Hat 
Ila lf Anterior Pituitaries. All HAP treated with 1 
ng/ml LRH while cross-hatching indicates those also 























































0.1 1 10 
ARGININE VASOTOCIN 
ng;ml 
Figure 9. l·:ff'cct of AVT on Prolactin Heleased Into Media From 
~strogen-Progesterone Primed Castrate Male Hat 
Half Anterior Pituitaries. Cross-hatching indi-
cates those HAP incubated with AVT. Expressed as 
mean + S. E. ( n = 6) . 
1n those HAP incubated with 0.1, 1 and 10 ng/ml AVT (Table XI). An 
increase in prolactin concentration was observed in those glands re-
cci~ing 10 and IOO ng/ml AVT with lhe increase being significant 
(P < .01) in those HAP receiving 100 ng/ml AVT (Table XI). 
Piluilary Incubation VI 
59 
The effect of AVT on LRH stimulated LH release from intact female 
HAP was examined in this experiment. The results from this experiment 
indicate that AVT in concentrations of 10 and 100 ng/ml was capable of 
significantly (P < .02 and P < .05, respectively) reducing the LRH 
stimulated LH release (Figure 10). A non-significant reduction in LH 
release was also observed in those groups receiving 1 and 1000 ng/ml 
AVT. Again, AVT 1n the concentrations used in this experiment had no 
effect on prolactin release from the HAP of these intact female rats 
(Figure 11). 
As with the previously described pituitary incubations, HAP in-
cubated with LRH and AVT contained less LH than the control halves 
(Table XII). This was statistically significant (P < .01) in those HAP 
incubated with 1000 ng/ml AVT. Prolactin concentrations of these HAP 
were unaffected by the concentrations of AVT utilized in this ex-
periment {Table XII). 
Pituitary Incubation Vll 
The effect of AVT without LHH stimulation in the intact female 
rat was examined in this experiment. Figure 12 illustrates no signifi-
cant effect of 1 ng/ml AVT on LH released from intact female HAP. 
TABLE XI 
EFFECT OF AVT ON LH AND PROLACTIN CONCENTRATIONS 
OF LRH STIMULATED HALF ANTERIOR PITUITARIES 
FROM ESTROGEN-PROGESTERONE PRIMED 
CASTRATE MALE RATS 
Treatment 2 LHl 
LRH 177.46 + 25.29 -LHH + 0.1 ng/ml AVT 135.13 + 4.93 -
LHH 151.70 + 26.11 -
LIU! + 1 ng/ml AVT~ 140.43 + 10.31 -
LHH 147.45 + 12.08 -LHH + 10 ng/ml AVT 135.69 + 15.98 -
LRH 162.34 + 23.08 
LRH + 100 ng/ml AVT 161.49 + 22.16 -
l Expressed 1n ug/mg HAP, mean+ S.E. (n = 6). 
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Prolactin l 
3.91 + 0.26 
3.75 + 0.31 -
4.23 + 0.56 -4.27 + 0.62 -
3.50 + 0.51 
4.13 + 0.54 
2.72 + 0.27 
- 3 3.72 + 0.26 
2All HAP treated with l ng/ml LRH alone or with the indicated 
concentrations of AVT. 
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l' i gure IO. lo:f'f'ect of AVT on LHII Stimulated Lll Released Into 
Media From Intact Female Rat Half Anterior 
Pituitaries. All HAP treated with 1 ng/ml 
LHH while cross-hatching indicates those also 
incubated with AVT. Expressed as mean+ S.E. 
(n = 5). 















































Figure ll. Effect of AVT on Prolactin Heleased Into Media From 
Intact Female Rat Half Anterior Pituitaries. 
Cross-hatching indicates those HAP incubated 
with AVT. Expressed as mean+ S.E. (n ~ 5). 
o'' 
TABLE XII 
EFFECT OF AVT ON LH AND PROLACTIN CONCENTRATIONS 
OF LHH STIMULATED HALF ANTERIOR PITUITARIES 
FROM INTACT FEMALE RATS 
Treatment 2 LH1 
LHH 9.60 + 1. 71 -LHH + 1 ng/ml AVT 7.59 + 1.09 -
LRH 8.71 + 1.63 -LRH + 10 ng/m1 AVT 8.46 + 1.37 -
LRH 8.07 + 1. 72 -LRH + 100 ng/ml AVT 7.00 + 1. 57 -
LRH 9.26 + 2.25 
+ 1000 ng/ml AVT - 1.483 LIUI 5.50 + -
1J·:xpressed in ug/mg HAP, mean+ S.E. (n = 5). 
63 
Prolactin 1 
2.09 + 0.21 
1.93 + 0.14 
1.63 + 0.10 
1. 50 + 0.05 
1.98 + 0.28 
2.14 + 0.33 
1.51 + 0.14 
1.60 + 0.09 
2All HAP treated with 1 ng/ml LRH alone or with the indicated 
concentrations of AVT. 
3p < .01 vs. corresponding control. 
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Figure 12. Effect of AVT on LH Released 
Into Media From Intact 
Female Rat Half Anterior 
Pituitaries. Cross-
hatching indicates those 
HAP incubated with AVT. 
Expressed as mean + S.E. 
(n = 10). 
64 
65 
Prolactin release was also unaffected by the concentration of AVT used 
in this experiment (¥igure 13). 
Similarly, AVT did not significantly effect either the LH or pro-
lactin concentrations of these HAP when compared to their corresponding 
control halves (Table XIII). 
Pituitary Incubation VIII 
In an attempt to determine whether the effects of AVT were spe-
cific, the effects of AVP on LH release 1n both non-stimulated and LRH 
stimulated intact male HAP were examined. As depicted in Figure 14, no 
significant effect of 1 ng/ml AVP was observed on LH release from AVP 
treated halves when compared to non-treated control halves. AVP was 
also found to be without effect on prolactin release in these HAP 
(Figure 15). Similarly, AVP (1 ng/ml) had no effect on the LRH stim-
ulated LH release from these rats (Figure 16). However, AVP was found 
to significantly (P < .02) inhibit the release of prolactin from the 
HAP incubated with LHH (Figure 17). 
The concentrations of LH and prolactin in intact male HAP incu-
bated with AVP reveal that while AVP had no effect on LH concentra-
tion, prolactin was significantly (P < .01) reduced in those HAP 
incubated with AVP (Table XIV). However, when those glands were in-
cubated with LHH and AVP no significant effect on LH or prolactin 
concentrations was observed (table XV). 
125 Pituitary Homogenate Uptake of I-LRH 
The ability of anterior pituitary homogenates obtained from in-
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ng 1 ml 
Figure 13. Effect of AVT on Prolactin 
Released Into Medi:a From 
Intact Female Rat ~alf 
Anterior Pituitaries. 
Cross-hatching indicates 
those HAP incubated with 
AVT. J~xpressed as mean 





EFFECT OF AVT ON LH AND PROLACTIN CONCENTRATIONS 
OF HALF ANTERIOR PITUITARIES FROM 
INTACT FEMALE HATS 
31.35 + 8.40 
26.09 + 7.56 





2.35 + 0.40 





































ng 1 ml 
Figure 14. Effect of AVP on LH Released 
Into Media From Intact Male 
Rat Half Anterior Pitui-
taries. Cross-hatching 
indicates those HAP incu-
bated with AVP. Expressed 









































ng 1 ml 
Figure 15. Effect of AVP on Prolactin Re-
leased Into Media From Intact 
Male Rat Half Anterior Pitui-
taries. Cross-hatching indi-
cates those HAP incubated 
with AVP. Expressed as mean 






































Figure 16. Effect of AVP on LRH stimulated 
LH Released Into Media From 
Intact Male Rat Half Anterior 
Pituitaries. All HAP incu-
bated with 1 ng/ml LRH while 
cross-hatching indicates 
those also incubated with 
AVP. Expressed as mean + 
S.E. (n=lO). 
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Figure 17. Effect of AVP on Prolactin Re-
leased Into Media From Intact 
Male Rat Half Anterior Pitui-
taries. Cross-hatching indi-
cates those HAP incubated 
with AVP. Expressed as mean 
+ S.E. (n = 10). 





EFFECT OF AVP ON LH AND PROLACTIN CONCENTRATIONS 
OF HALF ANTERIOR PITUITARIES 
FROM INTACT MALE RATS 
24.34 + 4.03 
25.02 + 3.15 
1Exprcssed in ug/mg HAP, mean+ S.E. (n 10). 
2 1 ng/ml. 
3 P< .01 vs. control. 
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Prolactin1 
4.44 + 0.38 
3.32 + 0.303 
TABLE XV 
EFFECT OF AVP ON LH AND PROLACTIN CONCENTRATIONS 
OF LRH STIMULATED HALF ANTERIOR PITUITARIES 
FROM INTACT MALE RATS 
Treatment LH1 
LRH2 27.52 + 6.70 
uul + 1 ng/m1 AVP 35.54 + 6.09 
1 in ug/mg HAP, (n 10). Expressed mean + S.E. 
2 1 ng/ml. 
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Pro1actin1 
1. 83 + o. 24 
1.47 + 0.31 
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concentrations of 10 and 50 nM was found to significantly (P < . 01 and 
) d . 1 12 5 f th t . . . t h t P < .05 1sp ace I-LRH rom e an er1or p1tu1 ary omogena es. 
Maximal displacement was found to occur at 100 nM LRH with no addition-
al displacement observed at 1000 nM LRH. Figure 19 demonstrates the 
inahility of AVT to displace the 125 r-LRH from the pituitary homo-
genate. Only at very high concentrations was AVT found to be able to 
125 non-significantly displace the I-LRH from the pituitary tissue. 
The ability of LRH to displace 125 r-LRH from pituitary tissue ob-
tained from estrogen-progesterone primed castrate male rats is de-
picted in Figure 20. All results were analyzed using the one-way 
analysis of variance and the student t-test. In contrast to those re-
sults observed in the intact male pituitary homogenate, AVT was found 
to biphasically facilitate the binding of 125 r-LRH to the pituitary 
tissue (figure 21). This increased binding was found to be significant 
(P < .Ol) at 50 nM AVT. However, the addition of 100 and 1000 nM AVT 
f ' d t l h th b . d. . f 12 5 was oun o no onger en ance · e 1n 1ng o I-LRH. These values 
were not significantly different from those homogenates receiving only 
the 125 I-LHH. 
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Pituitary Homogenate by LRH. Expressed as 
mean+S.E. (n=3). 
1 
. P < .01 vs. 0 nM LRH 
2p < .05 vs. 10 nM LRH 
I I I I -I,~ 
I I I I ~ I) 
0 20 40 60 80 100 1000 
nM AVT 
Figure 19. Displacement of 125I-LRH From Intact Male Rat 
Pituitary Homogenate by AVT. Expressed as 
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Progesterone Primed Castrate Male Rat 
Pituitary Homogenate by LHH. Expressed 
asmean+S.E. (n=3). 
0 
lp < .05 vs. 0 nM LRH 
2p < .01 vs. 10 nM LRH 
20 410 6o a'o 
nM AVT 
125 Displacement of I-LHH From Estrogen-
Progesterone Primed Castrate Male Rat 
Pituitary Homogenate by AVT. Expressed 
as mean+ S.E. (n = 3). 
lp < .Ol vs. 0 nM AVT 2P < .01 vs. 50 nM AVT 




Much confusion exists concerning the site(s) of action of the 
antireproductive properties of arginine vasotocin. Some investigators 
have suggested that AVT exerts its antireproductive properties on the 
pituitary gland (Pavel et al., 1973c; Vaughan et al., l975b) while 
others have suggested an effect on the gonads (Pavel and Petrescu, 
1966; Moszkowska and Ebels, 1968; Johnson et al., 1978). Discrepancies 
exist between those investigating the influence of AVT on the pituitary 
(Vaughan et al., l975b; Demoulin et al., 1977). This confusion may in 
part be due t<J different steroid environments in animal models used in 
Lhe various experiments. This work examined the effect of AVT on LRH 
stimulated LH release and prolactin release from the pituitary of the 
adult rat. These parameters were examined under var1ous steroid en-
vironments offered by several different animal models. 
In Vivo Administration of Peptide 
An attempt to determine the effect of chronic AVT treatment on the 
pituitary's responsiveness to LHH in male rats was undertaken and indi-
cated that the LHII-induced rise of serum LH was modulated by this 
pineal peptide. LHI! administration caused an increase in serum LH 
concentrations in all groups of animals within 30 minutes of admini-
stration. In most groups LH concentration returned to basal 
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levels by 120 minutes. This type of a response to an LRH stimulus is 
in agreement with Debeljuk et al. (1974) who found a significant in-
crease in LH within 20 minutes of the intravenous administration of the 
peptide in intact male rats. Greeley et al. (1978) also observed a 
significant increase in LH after LRH administration in intact male rats. 
They found the LH levels 1n most rats were returning to basal levels 
within 80 minutes. This 1s also 1n agreement with the response ob-
served 1n this experiment. 
However, 1n rats receiving increasing concentrations of AVT, a 
decrease in LH released in the response to the challenge of LRH was 
observed. The 30 minute response in those rats receiving 0.1 or 1.0 
ug AVT per day was significantly (P< .05) greater than those rats re-
ceiving neither AVT nor LRH while the response in the group receiving 
10 ug AVT per day was not significantly greater than those which re-
ceived neither AVT nor LRH. This was interpreted as indicating that 
10 ug AVT per day reduced the pituitary's sensitivity to LRH so that 
LRH could no longer stimulate a significant release of LH over the 
control rats. While the 30 and 60 minute LH levels in the groups re-
ceiving 0.1 and 1.0 ug AVT were lower than those not receiving AVT, 
this reduction was significant (P < .05) only at the 60 minutes post-
injection period. All values had returned to base levels by either 
120 or 180 minutes. 
This decrease in the pituitary's sensitivity to LRH may be ex-
plained by a direct or indirect effect on the LRH receptor. It is 
possible that AVT was competing for and occupying the LRH receptors 
in such a way that LRH could not ·bind to its receptors or once LRH 
was bound to its receptor site it could not elicit a biological 
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response. Several synthetic inhibitory analogues of LRH, including 
d . 2 6 h 2 . 6 d 2 h 6 h b esH1s -D-Leu -LRH, D-P e -D-Leu -LRH an D-Phe -D-P e -LRH ave een 
observed to inhibit LH release for 4 hours after administration in the 
immature rat (Schally et al., 1976). As much as 500 ug was reqtiired to 
elicit this response. Thus, it is possible to inhibit LH release with 
inhibitory analogues that are believed to compete with LRH for LRH 
binding sites on the gonadotrope plasma membranes (Spona, l974a). 
Inasmuch as LRH and AVT contain the same C-terminal amino acid content 
it may be that AVT acts as an inhibitory analogue of LRH. This type of 
action of AVT would have required a gradual release of AVT from the 
subcutaneous injections each day since large concentrations of syn-
thetic analogues are required over a shorter period of time than that 
utilized i.n the present study. The rate of absorption from these in-
jections was not measured. 
As previously mentioned, a second possibility is that AVT di-
rectly affects either the LRH receptor or the cellular mechanism of 
action of LRH in such a way to render LRH incapable of eliciting a bio-
logical response. It is interesting to note that Cheesman et al. 
(1977a, l977b) found that the intravenous and intraventricular ad-
ministration of AVT will result in a suppression of the preovulatory 
surge of LH. It is possible that AVT was affecting the action of 
endogenous I.HII on the pituitary although they concluded otherwise 
since the AVT f~iled to affect the LH levels in either diestrous or 
ovariectomi.zed female rats. However, they failed to account for the 
differing steroid environments that exist in each of these animal 
models. 
Another possible explanation for the antigonadotropic action of 
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AVT may be a direct effect of the pineal peptide on the testis and 
thereby indirectly affecting the response of the pituitary to LRH. By 
affecting steroid synthesis, AVT could alter the ratio of testosterone 
to estrogen and progesterone. It has been shown that in 2-month old 
castrate rats a combination of testosterone (1.5 mg) and 17B-estradiol 
(0.05 mg) given subcutaneously in oil resulted 48 hours later in a 
decreased LH responsiveness to 100 ng LRH g1ven intravenously 
(Debeljuk et al., 1974). The same laboratory has also shown that low 
doses of estradiol benzoate will in itself depress the pituitary's 
response to LHH in the intact male rat (Debeljuk et al., 1972). Kul-
karni et al. (1977) also reported that testosterone proprionate in 
combination with estrogen suppressed the facilatory affect of estradiol-
l7B on the LH response to LRH in a dose-related manner. Assuming AVT 
affects steroid synthesis, data has been reported that may explain the 
pituitary's altered responsiveness to LRH. 
The results in this work are of particular interest as Milcu and 
colleagues (1975) reported that daily injections of a bovine pineal 
polypeptide for 3 or 6 days to intact male rats resulted in a de-
crease of testosterone both in serum and testicular tissue. The ex-
traction procedure used to isolate this peptide was identical to that 
used by Milcu et al. (1963) when AVT was first tentatively identified 
in the bovine pineal gland. These results were interpreted as meaning 
that the pineal gland plays an inhibitory role at the level of 
testosterone synthesis. 
Based on these observations it 1s possible the daily administra-
tion of AVT decreased testosterone, thus altering the testosterone to 
estrogen and progesterone ratios in such a way that a combination of 
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these steroids rendered the pituitary less responsive to exogenous LRH. 
A clwn1,~e in 1.11 concentrations at time 0 might have hecn expected as a 
r·csul.t o(' Lhc altered steroid environment. In the group receiving 0.1 
ug AVT a slight but significant (P < .05) decrease in pre-injection 
LH was observed when compared to controls. However, according to a re-
cent study by Steinberger et al. (1977), changes in plasma steroids 
such as a decrease in testosterone induced by chronic administration of 
estradiol benzoate need not result 1n a significant change in plasma 
Ul levels. Therefore a change in the concentration of circulating 
steroids might have occurred during AVT treatment without affecting a 
large change in plasma LH levels. An effect of AVT on gonadal steroids 
is also suggested by the reports of Vaughan et al. (l976d). Acute in-
travenous administration of AVT to estrogen-progesterone primed male 
rats resulted 1n no effect on serum LH concentrations, thus suggesting 
the necessity of chronic AVT treatment and LRH stimulation. These re-
sults together with the results of the present study suggest the ef-
fect of AVT in this experiment may have been directed toward gonadal 
steroid biosynthesis. 
The daily administration of AVT had no significant effect on pro-
lactin release in this experiment (Table III). This is at variance 
with the data of Vaughan et al. (1976d) who reported that AVT will re-
lease prolactin in a dose dependent fashion. However, major differ-
ences in experimental design may explain the difference in the results. 
They used an acute preparation involving the intravenous administra-
tion of AVT to either intact or pinealectomized, estrogen-progesterone 
primed male rats. Blood was collected for only 20 minutes after the 
administration of AVT. It was determined that prolactin levels in 
most instances had peaked at 10 minutes and were returning to basal 
levels by 20 minutes. Other important differences include the use of 
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a different route of administration of AVT and the use of a different 
animal model. These observations imply the effect of AVT on prolactin 
release is very short lived. Therefore, it is not surprising that AVT 
was observed to have no effect on prolactin release in this work. How-
ever, Cheesman et al. (l977b) found that the intravenous administration 
of AVT resulted in a suppression in the proestrous surge of prolactin. 
Differences in experimental design and animal models may also account 
for the discrepancies between this study and the results obtained by 
Cheesman and colleagues. 
In Vitro Experiments 
One of the major advantages of any in vitro techniques is the 
ahility to control many of the variables found in vivo. In an attempt 
to more closely control the steroid environment, a modification of the 
.tn vitro pituitary incubation technique of Schally et al. (1972) and 
Mittler and Meites (1966) was used for part of the in vitro experi-
ments 1n this study. Using this technique, one HAP served as a control 
while its corresponding half served as the experimental tissue. 
Perhaps the major disadvantage with this technique is the po-
tential for cellular degeneration to occur during the incubation 
period. In an attempt to determine the degree of degeneration occur-
ring, GOT levels were measured in the media of incubated pituitaries. 
There was linear accumulation of GOT over the 6 hours incubation 
period, which would suggest a relatively c,onstant release of GOT from 
the !lAP and would argue against an increase in cellular degeneration 
had not occurred although the assumption has to be made that a small 
ucgr·ee of' degcnerati.on was occur·ring in those glands incubated with 
oxygen. 
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Light mi.croscopic examinati.on supported the conclusions drawn from 
the enzyme determinations. Those HAP incubated for 6 hours with oxygen 
contained significantly (P < .001) more pyknotic nuclei than fresh 
tissue; However, pituitaries incubated for 6 hours without oxygen 
also contained significantly (P < .001) more pyknotic nuclei than the 
fresh glands or those incubated for 6 hours with oxygen. A 15 fold 
increase in pyknotic nuclei was observed in those glands incubated 
wi.thout oxygen when composed to those incubated with oxygen. An in-
crease in loose connective tissue was also observed in those glands 
incubated without oxygen. These results along with the enzyme de-
terminations may be interpreted as indicating a slow cellular degenera-
ti.on was occurring over the 6 hour incubation. 
The functional status of the pituitary incubation technique was 
demonstrated by the ability of LRH to stimulate LH release in both the 
intact and estrogen-progesterone primed castrate male rat. In both 
models, 1 ng/ml LRH was found to significantly (P < .01 and P < .02, 
respectively) stimulate LH release into the media. This action of LRH 
is in agreement with accepted dogma (Schally et al., 1972; Schally et 
al., 1973). Using this technique, LRH was found to have no effect on 
prolactin release from HAP obtained from intact male rats. However, 
LHH was found to significantly (P < .05) release prolactin from the 
estrogen-progesterone primed castrate male rat HAP. This is believed 
to be the first report of such activity. 
Incubation of HAP with LHH was found to have no effect on gland 
concent.r•alions of either LH or prolactin in the i.ntact male rat HAP. 
The gland concentration of LH in LRH treated HAP from estrogen-
progesterone primed castrate male rat pituitaries was significantly 
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( P < • 001) less than control halves. No effect was observed on pro-
lactin gland concentration. These differences in LH concentrations may 
be explained both by an increase in synthesis of LH and an increase in 
sensitivity of the pituitary to LRH stimulation as a result of the 
estrogen-progesterone prime. Present doctrine suggests that estrogen 
exerts a dual effect on LH. It is believed that short term administra-
tion of estrogen results in a decrease in the pituitary's ability to 
release LII while long term administration results in both an 1ncrease 
in LH synthesis and increased responsiveness of the pituitary to LRH 
stimulation (Cooper et al., 1974; Vilchez-Martinez et al., 1974). The 
data just described agree with accepted dogma concerning long term ad-
ministration of estrogen. 
The effect of AVT on LRH stimulated LH release in HAP obtained 
from intact male rats was examined in pituitary incubations II and III. 
No significant effect of various concentrations of AVT with either 1 or 
10 ng/ml um on Lll release was observed in these incubations. This 
would indicate that the steroid environment of the intact male was not 
conducive for AVT lo exhibit antigonadotropic properties. This is in 
agreement with the report of Demoulin et al. (1977) in which AVT was 
found to have no effect on either basal LH secretion or LRH stimulated 
LH release from cultured pituitary cells obtained from intact male 
rats. However, this is in disagreement with Vaughan et al. (1975b) 
who reported lhal AVT was capable of releasing LH from HAP of intact 
85 
male rats. However these HAP in the latter study were not LRH stimu-
lated and were incubated for only 3 hours. It is possible that either 
or hol.h of' these d i f'f'crences i_n experimental design may have rcsul ted 
1 n the ohservat i om; to be at variance with each other. 
AVT was also observed to have no effect on prolaritin secretion in 
pituitary incubation II and III (Figures 3 and 5). Again, this is in 
disagreement with the results of Vaughan and colleagues (1975b). They 
reported that various concentrations of AVT (100 ng/ml to 10 ug) pro-
moted prolactin release from HAP in a dose related fashion. In pitui-
tary incubation II, the concentrations of AVT used were log doses from 
0.01 to 10 ng/ml while in pituitary incubation III log doses from l to 
100 ng/ml AVT were used. Therefore, the concentrations of AVT utilized 
in this work were, for the most part, less than those used by others. 
This might explain the difference in results observed. 
Hemoval of testicular steroids by castration also resulted in no 
significant effect of AVT on either LRH stimulated LH release (Figure 
6) or on prolactin release from incubated pituitaries (Figure 7). How-
ever, replacement of the testicular steroids with estrogen and pro-
gesterone 1n the animals resulted in a decrease in the amount of LRH 
stimulate LH released into the media by those HAP incubated with AVT 
(Vigure 8). This inhibition was significant (P < .02 and P < .05, re-
spectively) with 0.1 and 10 ng/ml AVT. Prolactin release was not 
significantly affected in the pituitaries obtained from these rats 
(Figure 9). 
These results indicate that estrogen and/or progesterone are re-
quired for AVT to exhibit an antigonadotropic action. It has been 
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reported that the effects of estrogen on LH appears to be dependent on 
several factors. The time course of administration of the steroid is 
important as a biphasic effect is observed (Jackson, 1973; Libertum et 
al., 1974; Apfelbaum and Taleisnik, 1976). It appears that short term 
administration of estrogen results in a decreased sensitivity of the 
pituitary to LHH while long term administration results in an enhanced 
sensitivity to LHH. Liu and Jackson (1977) have also reported that 
in vitro a) estrogen and LRH stimulated the incorporation of radioac-
tive glucosamine into LH while having no effect on radioactive amino 
acid incorporation into LH; b) estrogen and LRH stimulate the release 
of newly synthesized LH (synthesis involving both protein and carbo-
hydrate elongation); c) both estrogen and LRH act synergistically to 
enhance radioactive incorporation of glucosamine into LH while only 
estrogen enhances glucosamine uptake and incorporation into total pro-
tcln, and; d) estrogen potentiates the effects of LRH on the release 
of immunoreactive LH and of glucosamine and amino acid labeled LH. 
Little has been reported concerning the effects of progesterone 
on LHH stimulated IR release. Howland (1976) found that progesterone 
potentiates the LRH stimulated LH release in ovariectomized testa-
sterone propionate treated female rats. Debeljuk et al. (1974) re-
ported that in the intact rat 17-a-hydroxyprogesterone and pregnandiol 
did not mod.ify the pituitary's response to LRH. However, in the 
castrate male rat 20-a-d.ihydroprogesterone or prcgnandione slightly 
i nh i b i Led Lhe Lim s L i mula ted LH release. When progesterone was ad-
ministered with estradiol an augmentation of the pituitaries sensi-
tlvity to LHH was observed (Campbell and Schwartz, 1977). 
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Thus the action of AVT might involve a decrease in the estrogen 
induced incorporation of glucosamine into LH. This would necessitate 
LH synthesis involving the incorporation of carbohydrate moieties on 
the polypeptide chain to occur during the incubati.on .. However, LH syn-
thesis from amino acids precursors would not have to be occurring. 
Thus, AVT could be interfering with the final steps o~ LH biosynthesis. 
Another possible explanation concerning the antigonadtropic activity 
of AVT may involve interference with the potentiation that exists be-
tween estrogen and LRH concerning the release of LH. Closely related 
is the suggestion by Hoff et al. (1977) that "two pools" of gonado-
tropins exist in women. Pool 1 consists of releasable LH while pool 2 
is involved with the synthesis and storage of LH. They suggest that 
estrogen exerts a positive effect on pool 2 while exerting a negative 
effect on pool l. They further hypothesize that estrogen potentiates 
the LRH stimulated activation of pool 2 to pool l. De Koning et al. 
(1976) also reported the existence of a readily releasable pool of LH 
and a second pool that requires the LRH induced synthesis of a protein 
before the pool could be released. They determined this new protein 
not to be newly synthesized LH. It is possible that AVT may interfere 
with this conversion of pool 2 to pool 1. 
Perhaps closely related to the synergism or potentiation that 
exists between estrogen and LRH is yet another possible explanation for 
the antigonadotropic activity of AVT. It is possible that AVT could be 
interfering with LHH bindi.ng to its receptors. This would necessitate 
the existence of at least two different receptor types. One of these 
receptor types would need to be found predomi.nantly in the estrogen-
progesterone primed castrate male rat and not found in any great 
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quantity in either the intact or castrate rat. Spona (l974b) has de-
scribed the existence of high affinity-low capacity and low affinity-
high capacity receptors. He further reported that a pituitary binding 
site for LRH is lost upon ovariectomy and may be restored upon treat-
ment with steroids. These receptors were apparently lost by 30 days 
after ovariectomy and are classified as high affinity-low capacity re-
ceptors. It was also reported that pituitaries from intact male rats 
also have two distinct receptor types (Spona, 1975). However, he con-
cluded that the receptors found in the male were different from those 
found in the female. It is interesting to note that when a castrate 
male rat was primed with estradiol benzoate, the high affinity re-
ceptors disappeared leaving only the low affinity receptors. These 
low affinity receptors had the same affinity constant as the high af-
finity receptors of the female which were lost upon ovariectomy and 
reappeared with cstrogcn-prog~sterone replacement. 
If these purported high affinity receptors are involved in the ob-
served effects of AVT on LH release then the release of LH from the 
anterior pituitary of the intact female rat should be affected similar 
t.o that of' the estrogen-progesterone primed castrate male rat. Indeed, 
when anterior pituitaries from intact female rats were challenged with 
Lim, lO and 100 ng/ml AVT significantly (P < .02 and P < .05, re-
spectively) inhibited the LRH stimulated LH release from these glands 
(Vigure 10). AVT was found to have no effect on prolactin secretion 
from HAP obtained from these rats (Figure ll). 
These data would add further support to the hypothesis that es-
trogen or progesterone or a combination of these steroids are necessary 
for AVT to exert an antigonadotropic action. As the rats utilized in 
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thi.s experiment were females at various stages ofestrous cycle, no 
statement can be made concerning the circulating levels of steroids 
other than the assumption that all rats should have experienced a surge 
of steroids within several days of sacrifice. The HAP incubated with 
AVT and LHII in all the incubations discussed contained less immunoas-
sayable LH than the LHH treated control halves (Tables VIII, IX, X, XI 
and XII). Although usually not statistically significant, this reduc-
tion in LH nevertheless occurred in every treatment group regardless 
of the steroid environment. This observation suggests that AVT could 
be affecting the synthesis of LH in vitro. This reduction in synthesis 
need not involve the synthesis of LH from amino acid precursors but may 
involve the association of the a- and B-subunits or the addition of the 
carbohydrate moieties to the protein molecule which may not depend on 
the steroid environment of the rat. This further supports the hy-
pothesis that the inhibition of LRH stimulated LH release observed in 
those rats exposed to estrogen and progesterone was due to a reduction 
of the faci.litory action of estrogen on the LRH stimulated LH release~ 
The facilil;ory acti.on may occur at the LHH receptors or at some other 
step in the LH releasing mechanism. 
The prolactin concentrations of these HAP were elevated in most 
groups receiving AVT (Tables VIII, X, and XI) except those intact male 
rats in pituitary incubation III (Table IX}. In pituitary incubation 
II, signjfi.cant (P < .02) elevation in glandular prolactin was ob-
served after treatment with 0.01, 0.1 and 1.0 ng/ml AVT (Table VIII). 
In pituitary incubation IV, significant (P< .05 and P < .01, re-
spectively) elevation was observed with 0.1 a11d lOU ng/ml AVT (Table 
X). s·igni.fieant (P < .01) elevation in prolactin was observed in 
those HAP incubated with 100 ng/ml AVT in pituitary incubation V 
(Table XI). The prolactin concentration in those HAP in pituitary 
incubation VI incubated with AVT was not significantly affected 
(Table XII). 
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The increase in immunoassayable prolactin in those HAP incubated 
with AVT along with no significant effect on release from these HAP im-
plies an increase in synthesis of immunoassayable prolactin. This is 
of interest as a prehormone for prolactin has been identified (Evans 
et al., 1977; Maurer et al., 1977; Royal and Chrambach, 1975). It has 
been determined that preprolactin contains 29 extra amino acids at-
tached to the N-terminal portion of the hormone. It is possible that 
AVT may stimulate the conversion of preprolactin to prolactin. Also 
of interest are the reports of Vaughan et al. (l975b) and Blask et al. 
(1976) that AVT was observed to release prolactin in vivo and in vitro 
using larger doses of AVT than utilized in the present study. It would 
be of interest to determine if these larger doses of AVT also stimu-
lated the synthesis of prolactin and also if the results reported 1n 
this work would release prolactin with larger doses of AVT. 
The one exception to the apparent AVT stimulation of gland con-
centrations of prolactin was in pituitary incubation III in which the 
HAP received 10 ng/ml LRH as well as AVT. In this experiment, 10 ng/ml 
AVT was found to significantly (P < .02) reduce prolactin glandular 
concentrations (Table IX). These results are difficult to reconcile 
when compared with the rest of the experiments; however, the effect of 
LO ng/ml LHH on prolactin synthesis and release was not examined and 
may be a possible explanation. 
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The results of pituitary incubation VII indicate that l ng/ml AVT 
does not affect basal LH release from the non-LRH stimulated HAP ob-
tained from intact female rats (Figure 12) but does affect the LRH 
stimulated LH release as observed in pituitary incubation VI (Figure 10). 
However, l ng/ml AVT did not significantly inhibit LRH stimulated LH 
release in either estrogen-progesterone primed castrate or intact fe-
male rats (Figures 8 and 10) although less release was observed in the 
AVT treated halves. In agreement with the previously dis.cussed pitui-
tary incubations, slightly less LH was found in the AVT treated HAP 
(Table XIII). This may indicate the inhibitory effect of AVT on LH 
synthesis is independent of either LRH or steroid effects on the pitui-
tary. This adds more evidence to the suggestion previously discussed 
that the effect of AVT on LH synthesis is separate from the effect on 
LH release. 
Again AVT was observed to have neither a significant effect on pro-
lactin release nor synthesis in HAP obtained from intact female rats 
(Figure 13). This is in agreement with pituitary incubation VI where 
no affect of AVT was observed on prolactin gland concentration in the 
intact female rat. 
Pituitary incubation VIII was performed as an attempt to determine 
whether the effects of AVT on LH and prolactin were specific to AVT or 
were shared with the neurohormone AVP. Like AVT, AVP was found to have 
no effect on either non-LRH stimulated LH release or on prolactin re-
lease (Figures 14 and 15); however, these glands were obtained from 
intact male rats. In contrast to the results observed in all experi-
ments involving AVT, AVP was observed to have no effect on pituitary 
LH concentration (Table XIV). This may be interpreted as indicating 
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that AVT exhibits a specific effect on pituitary LH synthesis. AVP 
was also found to significantly (P < .01) reduce the glandular concen-
tration of prolactin (Table XIV). This is in contrast with all incu-
bations bul pituitary incubation III. 
The effects of AVP on LRH stimulated LH release from intact male 
rat HAP were found to be identical with those of AVT (Figure 16). How-
ever, AVP was found to significantly (P < .02) inhibit prolactin release 
(Figure 17). This is difficult to reconcile with the rest of the ex-
peri~ents, especially since LRH was found to have no effect on pro-
lactin release from intact male HAP (Table II). Again, consistent 
with the hypothesis that the effects of AVT on glandular LH concentra-
Lions is specific, AVP was found to have no significant effect on 
glandular LH concentrations. AVP was also found to slightly, but non-
significantly decrease glandular prolactin concentrations in these 
glands. This is in agreement with the previously discussed experiment 
where AVP was also observed to decrease prolactin concentration in HAP. 
One of the possible modes of action of AVT is the interference 
of this peptide with LRH binding to LRH binding sites. The technique 
of Pedroza et al. (1977) was used to investigate this possibility. 
Using this technique, LRH may bind to such structures as secretory 
granules as well as membrane receptor sites (Sternberger and Petrali, 
1975). However, such binding may be decreased due to the presence in 
the pituitary of enzymes involved with the degradation of LRH 
' 
(Schally et al., 1976). In order to avoid the degradation of LRH, the 
peptide Bactracin was added to the buffers. This antibiotic is known 
to inhibit the in vitro degradation of LRH in brain tissue (McKelvey 
et al., 1976) and pituitary tissue (Pedroza et al., 1977) incubated 
for 30 minutes. However, recent evidence has suggested that the pep-
tidase inhibitory activity of Bacitracin may be short lived and that 
total protection may exist for only 5 minutes at 0°C (Gruber, 1978). 
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If this LS the case then enzymatic degradation was taking place during 
the 30 mLnute incubation used in this work. 
Figure 18 depicts the ability of unlabeled LRH to displace 
125 ' 
I-LHH from a pituitary homogenate obtained from intact male rat 
pituitaries. The iodinated LRH (4.5 nM) was almost entirely displaced 
from the pituitary homogenate with 40 nM unlabeled LRH. The addition 
of either 100 or 1000 nM unlabeled LRH resulted in very little ad-
ditional displacement. In contrast, AVT concentrations up to 100 nM 
AVT was unable to displace 125 I-LRH (Figure 19). However, 1000 nM AVT 
was found to displace the iodinated LRH. Marshall et al. (1976) found 
that micromolar concentrations of AVP were capable of displacing 
125 f . b b d . I-Llm rom 1 ts mem rane oun receptor s1 tes. Therefore, the 
ability of AVT in micromolar concentrations to displace the binding of 
125 I-LRH from pituitary homogenate binding sites is not unexpected. 
These results are also in agreement with those observations from the 
intact male pituitary incubation experiments. Log concentrations of 
AVT up to 100 ng/ml (83.5 nM) were unable to affect the LRH stimulated 
LH release (Figures 2 and 4). 
In contrast, AVT was found to biphasically potentiate the binding 
of iodinated LHH to pituitary homogenates obtained from estrogen-
progesterone primed castrate male rats (Figure 21). In pituitary 
homogenates from these same animals, unlabeled LRH was found to dis-
125 place the I-LHH as expected (Figure 20). These results are 
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consistent with the pituitary incubation experiments in which AVT was 
found to affect the LRH stimulated LH release in HAP obtained from the 
estrogen-progesterone primed castrate male rat. Thus, an effect of 
AVT on LRH binding in these animals 1s predictable. However, it is 
125 
difficult to explain a potentiation of I-LRH uptake 1n pituitary 
tissue by AVT. One possible explanation may involve AVT serving as a 
substrate for the peptidases that degrade LRH. Credence would be added 
to this hypothesis if Gruber (1978) is correct in his suggestion that 
Bacitracin only inhibits the peptidase for 5 minutes at 0°C. This 
could be of physiological importance as degrading enzymes have been 
suggested as playing a role in the termination or regulation of local 
hormone action and concentration (Kuhl et al., 1977, 1978). However, it 
still remains difficult to explain the biphasic effect of AVT. This 
hypothesis also does not agree with the observations that AVT decreased 
the LHH stimulated LH release in pituitary incubations. 
Another possible explanation may involve the binding of AVT to 
the unique type of receptor that Spona (1974) suggested exists in the 
estrogen-progesterone treated rats. This type of action would con-
stitute heterotropic cooperativity. Heterotropic cooperativity is 
known to exist with regard to the effect of guanyl nucleotides on 
glucagon and angiotensin receptors (Kahn, 1976). It is believed that 
guanyl nucleotides may act in concert with the hormone receptor as an 
allosteric regulator of biological response. The mechanism(s) by 
which such an effect might occur include conformational changes in the 
structure of oligomeric receptors, or· polymerization or depolymeriza-
tion of receptorp iq the fluid membrane (Kahn, ~976). Therefore, it 
' ' 
is possible that AVT could bind to an allosteric site on the receptor, 
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enhance the receptors' ability to bind LRH by changing the conformation 
of the receptors, but render the receptor incapable of eliciting a 
biological response. However, this does not explain the biphasic re-
f 125 b' d' h' h b d . th' . t sponse o I-LRH ln lng w lc was o serve ln lS experlmen . 
Thus, pituitary incubation experiments have demonstrated that AVT 
will affect the LRH stimulated LH release in only those animal models 
exposed to estrogen and progesterone. These observations were con-
firmed by the ability of AVT to only affect the binding of 125r-LRH in 
the estrogen-progesterone primed castrate male rat. 
CHAPTER VI 
SUMMARY AND CONCLUSIONS 
Much of the literature concerning the antireproductive properties 
of arginine vastocin is confusing and contradictory. Previous inves-
tigators have hypothesized that AVT can affect either the gonads, 
pituitary or hypothalamus. However, several investigators disagree as 
to the effect observed at these target organs. For the present study 
it was hypothesized that AVT influences the pituitary's sensitivity 
to LHH as measured by changes in LH release. The influence of AVT on 
prolactin was also examined. This modulation of tropic hormone se-
cretion was examined both in vivo and 1n vitro in animal models of 
varying steroid environments. 
The results of the in vivo experiment indicate that AVT 1s capable 
of reducing the pituitary's sensitivity to LRH 1n the intact male rat. 
However, this influence could be the result of either a direct effect 
of AVT on the pituitary or an indirect effect due to AVT modulation of 
gonadal steroids. Prolactin secretion was not affected by AVT in this 
experiment. 
The results of the in vitro experiments indicate that AVT demon-
strates an inhibitory effect on the LHH stimulated LH release only in 
those animals previously exposed to estrogen and progesterone. AVT 
was observed to have no effect on pituitaries obtained from intact or 
castrate male rats. The LH concentrations of those HAP incubated 
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with AVT in all pituitary incubation experiments contained less im-
munoassayable LH than their corresponding control halves. This might 
indicate that AVT may affect LH synthesis in all animal models in-
vestigated while it is capable of reducing only the estrogen-
progesterone potentiation of the LRH stimulated LH release. These 
observations on the effect of AVT on LRH stimulated LH release in 
various animal models is strengthened by the obBervations of the in-
125 
fluence of AVT on the uptake of I-LRH in a pituitary homogenate. 
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125 AVT was found to be without significant effect on the I-LRH uptake 
in pituitary homogenate obtained from intact male rats. Predictably, 
AVT b d t . fl th t k f 125 . "t "t was o serve o 1n uence e up a e o . I-LRH 1n p1 u1 ary 
homogenate obtained from estrogen~progesterone primed castrate male 
rats. However, this effect was facilitory in nature. This may be ex-
plained on the basis of either an action of LRH peptidases on AVT or 
heterotropic cooperativity between AVT and the LRH receptor. 
AVT was observed to have no effect on prolactin secretion 1n any 
of the animal models utilized for pituitary incubations. However, in 
most cases AVT was observed to increase the gland concentrations of im-
munoassayable prolactin. 
In conclusion, these studies demonstrate that: 
l. AVT can influence the responsiveness of the anterior pituitary 
to LRH both in vivo and jn vitro; 
2. At least the in vitro response is dependent upon animals 
being exposed to estrogen and progesterone; 
3. AVT can also reduce the in vitro glandular concentration of 
Uf and increase that of prolactin; and 
4. AVT does not influence prolactin release in vivo or in vitro 
under the experimental conditions examined in the experiments de-
scribed in this dissertation. 
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